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Methods for Global Characterization of Chromatin Regulators in Human Cells 
Abstract 
 
  Chromatin is a multi-layered structure composed of DNA, nucleosomes, histone 
modifications, and associated proteins that critically affects genome function. Recently 
developed sequencing technologies enable genomewide characterization of certain aspects of 
chromatin structure, including nucleosome positioning and histone modifications. However, 
chromatin proteins present several challenges due to their dynamic nature and variable 
association with DNA. Chromatin proteins such as Polycomb regulators and heterochromatic 
factors play critical and global roles in epigenetic repression and hence new approaches are 
needed for their study. 
  We first sought to identify sequences that recruit Polycomb repressive complex 2 (PRC2) 
in mammalian cells. We combined chromatin immunoprecipitation with sequencing (ChIP-seq) 
to map the candidate transcription factor YY1, and found that it does not correlate with PRC2 
localization, suggesting that YY1 is not directly involved in PRC2 recruitment. We also 
identified GC-rich sequences that are necessary and sufficient for PRC2 recruitment. Yet 
attempts to map additional Polycomb proteins and other repressors using ChIP-seq proved 
difficult. 
  Since chromatin proteins are often broadly, secondarily or transiently bound to DNA, 
they are difficult to crosslink. Antibody quality also varies, further hampering ChIP-seq 
technology. Here, we adapt DamID, a method for mapping chromatin regulators that uses a 	 ﾠ iv	 ﾠ
fusion enzyme and that does not rely on crosslinking or antibodies, for high-throughput 
sequencing. We show that DamID-seq can be used to globally characterize chromatin repressors 
in human cells. 
We used DamID-seq to map the binding of 12 chromodomain-containing and related 
proteins in K562 cells. We found that these proteins cluster into two modules: 1) Polycomb-
related and 2) heterochromatin-related. Polycomb proteins bind developmental genes, while 
heterochromatin proteins bind broad olfactory receptor (OR) and zinc finger (ZNF) domains. 
Surprisingly, unlike other Polycomb proteins, CBX2 uniquely binds genes involved with 
modifying proteins.  
Our findings advance the model that the genome is compartmentalized into domains, and 
identify the distinct protein components that associate respectively with Polycomb and 
heterochromatin domains in human cells. We expect that DamID-seq, along with further 
advancements in characterizing the three-dimensional organization of chromatin, will bring us 
towards a better understanding of the role of chromatin in differentiation, development, and 
disease. 
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ABSTRACT 
 
A succession of technological advances over the past decade have enabled researchers to 
chart maps of histone modifications and related chromatin structures with increasing accuracy, 
comprehensiveness and throughput. The resulting datasets highlight interplay between chromatin 
and genome function, dynamic variations in chromatin structure across cellular conditions, and 
emerging roles for large-scale domains and higher-ordered chromatin organization. Here we 
review a selection of recent studies that have probed histone modifications and successive layers 
of chromatin structure in mammalian genomes.  
 
INTRODUCTION 
 
  The initial sequencing of the human genome a decade ago marked a shift away from a 
gene-centric paradigm and prompted many new lines of genome-scale investigation. An 
important emerging area relates to the packaging of DNA into chromatin and specifically how 
cell type-specific chromatin organization enables differential access and activity of regulatory 
elements and the manifestation of unique cellular phenotypes. 
  Eukaryotic chromatin structure can be viewed as a series of superimposed organizational 
layers (Felsenfeld and Groudine 2003; Schones and Zhao 2008) (Figure 1.1). At the root is the 
DNA sequence itself and its direct chemical modification by cytosine methylation (Law and 
Jacobsen). The DNA is folded into nucleosomes, the fundamental units of chromatin, that 
comprise approximately 147 bp of DNA wrapped around a histone octamer. The nucleosomal 
histones H2A, H2B, H3 and H4 can be chemically modified, and exchanged with variants.    5 
 
 
 
 
 
 
Figure 1.1. Layers of chromatin organization in the mammalian cell nucleus.  
Genomic DNA is methylated on cytosine bases in specific contexts, and is packaged into 
nucleosomes, which vary in histone composition and histone modifications; these features 
constitute the primary layer of chromatin structure. Here, different histone modifications are 
indicated by colored dots, and histone variants, such as H2A.Z, are shaded brown. DNA in 
chromatin may remain accessible to DNA-binding proteins such as transcription factors (TF) and 
RNA polymerase II (RNAPII), or may be further compacted. Chromatin can also organize into 
higher-order structures, such as lamina-associated domains and transcription factories. Each 
layer of organization reflects aspects of gene and genome regulation.   
 
   6 
 
Figure 1.1 (Continued). 
     7 
The nucleosome positions along with the variants and modifications make up the primary 
structure of chromatin. Finally, three-dimensional models of chromatin in the living cell are now 
being developed with increasing precision and propose additional sophisticated layers of 
regulation through higher-order organization and nuclear compartmentalization.  
  With increasing knowledge of chromatin structure and its attributes at different genomic 
loci and in various cell types comes the challenge to elucidate which elements and regulatory 
processes determine this structure. Specific chromatin configurations may be dictated by DNA 
sequence, DNA methylation patterns, transcription factors and other regulatory proteins, and 
transcriptional activity, and may be maintained through epigenetic controls rooted in the 
chromatin machinery (Margueron and Reinberg). Sequence features such as CpG islands, 
promoters and repetitive elements tend to assume characteristic modification patterns and 
chromatin states. These patterns result from complex mechanisms involving trans-acting factors 
that are subject to intense investigation but remain poorly understood (Margueron and Reinberg ; 
Bernstein, Meissner et al. 2007; Simon and Kingston 2009). These distinctive chromatin 
configurations facilitate targeting of transcription factors and regulatory machinery to active 
genomic elements within expansive mammalian genomes. As chromatin patterns at a particular 
locus are intimately related to underlying regulatory processes, they may vary markedly 
depending on cellular context. In particular, chromatin is heavily influenced by transcription 
factor networks and transcriptional processes which extensively harness chromatin modifiers and 
nucleosome remodelers (Li, Carey et al. 2007). In certain cases, environmental and stochastic 
events may invoke stable alterations in chromatin patterns, though our understanding of the 
output of such effects remains minimal (Jirtle and Skinner 2007).  
  Large-scale mapping of histone modifications and related structures has emerged as a   8 
powerful means for characterizing the determinants as well as the functional consequences of 
chromatin structure. Here, we review recent studies that have applied technologies, such as 
ChIP-seq, to interrogate chromatin structure across the genome in diverse cell types, with an 
emphasis on mammalian models. We will briefly present the technological developments that 
have punctuated the shift from a gene-centric to genomewide view. Then we will discuss the 
current knowledge of the primary structure of chromatin, focusing on the global patterns, 
functions, and dynamics of histone modifications that overlay sequence features such as 
promoters, enhancers, and gene bodies. Finally, we will discuss notable recent studies that 
illuminate the link between histone modifications and higher-order chromatin domains. 
 
FROM GENE-CENTRIC TO GENOMEWIDE 
 
For the past several decades, chromatin biology has been guided by a succession of 
methodologies for probing features such as chromatin accessibility, DNA methylation, the 
locations, compositions and turnovers of nucleosomes, and the patterns of post-translational 
histone modifications. Technological advances in microarrays and next-generation sequencing 
have enabled many of these assays to be scaled genomewide. Notable examples include the 
DNaseI-seq (Boyle, Davis et al. 2008; Hesselberth, Chen et al. 2009), FAIRE-seq (Giresi, Kim et 
al. 2007), and Sono-seq (Auerbach, Euskirchen et al. 2009) assays for chromatin accessibility; 
whole genome and reduced-representation bisulfite sequencing (BS-seq) (Meissner, Mikkelsen et 
al. 2008; Lister, Pelizzola et al. 2009) and MeDIP-seq (Down, Rakyan et al. 2008) assays for 
DNA methylation; and the MNase-seq (Schones, Cui et al. 2008; Kaplan, Moore et al. 2009) and 
CATCH-IT (Deal, Henikoff et al.) assays for elucidating nucleosome positions and turnovers,   9 
respectively. These technologies and their integration have been extensively reviewed elsewhere 
(Hawkins, Hon et al. ; Park 2009). In this section, we will focus on histone modifications and, in 
particular, on how genomewide ChIP-seq mapping studies have enhanced our understanding of 
the chromatin landscape. 
 
Mapping histone modifications genomewide.  
 
  While chromatin immunoprecipitation (ChIP) has been used since 1984 (Gilmour and Lis 
1984; Solomon and Varshavsky 1985) to probe chromatin structure at individual loci, its 
combination with microarrays, and more recently next-generation sequencing, has advanced far 
more precise and comprehensive views of the modification landscapes, highlighting roles for 
chromatin structures across diverse genomic features and elements not appreciated in targeted 
studies. The basis of ChIP is the immunoprecipitation step in which an antibody is used to enrich 
chromatin that carries a histone modification (or other epitope) of interest. In ChIP-seq, next-
generation technology is used to deep sequence the immunoprecipitated DNA molecules and 
thereby produce digital maps of ChIP enrichment. An example is the comprehensive work by the 
Zhao group to profile 39 different histone methylation and acetylation marks genomewide in 
human CD4+ T cells (Barski, Cuddapah et al. 2007; Wang, Zang et al. 2008). These maps and 
similar datasets (Guenther, Levine et al. 2007; Heintzman, Stuart et al. 2007; Mikkelsen, Ku et 
al. 2007) have associated particular modifications with gene activation or repression and with 
various genomic features, including promoters, transcribed regions, enhancers, and insulators 
(Figure 1.2).  
     10 
 
Figure 1.2. Histone modifications demarcate functional elements in mammalian genomes. 
Promoters, gene bodies, an enhancer, and a boundary element are indicated on the representative 
genomic interval. Active promoters are commonly marked by H3K4me2/3, acetylation, and 
H2A.Z. Transcribed regions are enriched for H3K36me3 and H3K79me2. Repressed genes may 
be located within large domains of H3K9me2/3 or H3K27me3. Enhancers are relatively enriched 
for H3K4me1/2, H3K27ac, and p300. The CTCF protein binds many sites that may function as 
boundary elements, insulators or structural scaffolds. These features organize the DNA and 
distinguish functional elements within the large expanse of genome. 
     11 
   
Box 1.1. ChIP-seq: Current limitations and future progress.   
Enabled by technological advances and plummeting costs of DNA sequencing, 
genomewide maps for histone modifications and related chromatin structures are being 
generated at ever increasing rates. Given this expanding reliance on ChIP-seq technology and 
data, there is a need for uniform implementation of data standards. The ENCODE Project 
(Birney, Stamatoyannopoulos et al. 2007) and the NIH Roadmap for Epigenomics (Bernstein, 
Stamatoyannopoulos et al. 2010) have established standards for experimental procedures, 
documentation and quality controls intended to ensure the quality and facilitate the portability, 
interpretation and integration of functional genomic data. 
  Questions also remain at the level of biological interpretation of ChIP-seq data. 
Inherent to ChIP technology is that it reports on the relative enrichment of a modification 
across a population of cells. Accordingly, it cannot discern the absolute level of these 
modifications, i.e. what fraction of histone tails at a given locus are modified, and may be 
confounded by cellular heterogeneity. The magnitude of enrichment signal is also an 
important consideration. A select few modifications typically show enrichments of 10- to 100-
fold and thereby offer particularly reliable metrics. Signals for many other epitopes tend to be 
subtler, but may be equally biologically important. In such cases, it can be difficult to 
distinguish whether perceived differences reflect technical issues such as inefficient 
immunoprecipitation, or true biological phenomena. Statistically significant trends can often 
be discerned through composite analysis of hundreds of genes or elements, but biological 
conclusions should be made with care when overall magnitude differences are incremental. 
Although these limitations are starting to be addressed by improved ChIP-seq procedures that 
increase sensitivity and reliability, there is an urgent need for orthogonal approaches.   12 
These and subsequent studies highlight the value of the comprehensive and less biased 
sequencing approaches for testing the generality of insights gleaned through gene-specific 
studies as well as for identifying altogether new associations and biological phenomena (Box 
1.1). 
 
Integrating ChIP-seq maps.  
 
The expanding body of chromatin data in the public domain has fostered many 
computational efforts aimed at integrating different data types, identifying novel relationships 
among histone modifications and related chromatin structures, and developing new hypotheses 
regarding their regulatory functions. Integrations of histone modification maps with chromatin 
accessibility, nucleosome positions, transcription factor binding, RNA expression and sequence-
based genome annotations are providing increasingly unified views of chromatin structure and 
function (Hawkins, Hon et al. ; Birney, Stamatoyannopoulos et al. 2007; Kaplan, Moore et al. 
2009).  
Two recent studies present innovative approaches for integrating genomewide chromatin 
maps (Hon, Wang et al. 2009; Ernst and Kellis), both of which were demonstrated on a 
compendium of ChIP-seq data for human CD4+ T cells (Barski, Cuddapah et al. 2007; Wang, 
Zang et al. 2008). Hon et al. applied a pattern-finding algorithm called ChromaSig to identify 
combinations of histone modifications at predetermined classes of regulatory loci, including 
promoters and enhancers. After validating that their approach identified known associations 
between modifications and expression levels, they applied it to regions outside of these elements 
and subsequently identified distinct chromatin signatures associated with exons and large-scale   13 
repressed regions. Ernst et al. used a multivariate Hidden Markov Model to discover biologically 
meaningful combinations a priori. They discovered 51 distinct chromatin states that could be 
sub-divided according to current genome annotations, including several promoter-associated, 
enhancer-associated and repressed states. This unbiased approach revealed the high information 
content provided by combinatorial modification patterns. It also confirmed striking functional 
distinctions between methylation marks affecting different residues or assuming different 
degrees of chemical modification (mono-, di- or tri-methylation). In contrast, the functional 
correlates of histone acetylation marks appeared to be less dependent on the specific residues 
involved, but rather on the overall degree of acetylation, consistent with previous studies in yeast 
(Durrin, Mann et al. 1991; Dion, Kaplan et al. 2007). 
Although their findings are largely consistent with prior knowledge of histone 
modification functions, these studies are significant for their forward-looking approaches to 
developing algorithms that integrate increasingly vast bodies of functional genomic data into 
coherent biological views. An important future direction will be an equally systematic 
characterization of chromatin-associated proteins, including the regulators that modify and 
otherwise interact with histones. Such data could facilitate perturbation of specific chromatin 
structures to thereby yield insight into their functions. This goal will be challenged by technical 
difficulties. However, a recent study in Drosophila that localized dozens of chromatin proteins, 
and thereby partitioned the genome based on their combinatorial binding patterns, provides a 
potential path forward (Filion, van Bemmel et al. 2010). 
 
 
   14 
HISTONE MODIFICATIONS ACROSS GENOMIC SEQUENCE ELEMENTS 
 
In this section, we will review the types and patterns of histone modifications that have 
been linked to major functional genomic elements, discuss their dynamics through cell 
differentiation and development, and touch upon functional studies that are beginning to give a 
mechanistic grounding to these observed patterns. 
 
High and low CpG content promoters (HCPs and LCPs).  
 
  Although mammalian promoter regions vary considerably in their positional relationships 
to genes, the DNA sequence proximal to the transcriptional start site (TSS) of a gene (e.g., the 
region +/- 2 kb) is frequently considered as a proxy. The patterns of histone modification across 
such regions offer insight into the regulatory state of promoters and genes, and have revealed 
important paradigms of gene regulation. 
  Mammalian promoters can be classified according to their sequence content, and this has 
proven to be useful for understanding their regulation (Figure 1.3). A majority of promoters 
coincide with regions of high GC content and CpG ratios, or ‘CpG islands’. These have been 
termed ‘high CpG content promoters’ or ‘HCPs’, in contrast to ‘low CpG content promoters’ or 
‘LCPs’. HCPs and LCPs have different histone modification patterns and distinct modes of 
regulation (Mikkelsen, Ku et al. 2007; Weber, Hellmann et al. 2007). The distinction between 
HCPs and LCPs is somewhat arbitrary and does not effectively address a number of intermediate 
CpG content promoters.  
     15 
 
 
 
 
Figure 1.3. Chromatin patterns and regulation by promoter class.  
Promoters may be classified according to their CpG content. High CpG and low CpG content 
promoters, HCPs and LCPs, respectively, are subject to distinct chromatin patterns and 
regulation. (a) HCPs have characteristics of accessible or ‘active’ chromatin by default. Active 
HCPs (e.g. housekeeping gene promoters) are enriched for H3K4me3 and subject to RNAPII 
initiation. They may be subject to additional regulation at the transition to elongation. (b) Poised 
HCPs (e.g. developmental regulator gene promoters in ES cells) are marked by the bivalent 
combination of H3K4me3 and H3K27me3. They may be subject to RNAPII initiation, but tend 
not to elongate or make productive mRNA. (c) Inactive HCPs carry ‘repressive’ chromatin 
modifications such as H3K27me3, and are relatively inaccessible to RNAPII. Unlike HCP 
chromatin, LCP chromatin appears to be selectively activated (e.g., by specific transcription 
factors or ‘TFs’). (d) Active LCPs are enriched for H3K4me3 and transcribed. (e) Poised LCPs 
may be marked by H3K4me2 without H3K4me3. (f) Inactive LCPs typically lack chromatin 
marks but may be DNA methylated. 
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Figure 1.3 (Continued).     17 
Incorporation of additional sequence features such as DNA motifs or DNA methylation patterns 
may result in a more precise and biologically-meaningful classification (Bernstein, Meissner et 
al. 2007; Straussman, Nejman et al. 2009). Nonetheless, the two classes provide a useful 
framework for understanding and distinguishing the functions and regulation of mammalian 
promoters.  
  Initial ChIP-chip studies in mammalian cells revealed punctate peaks of H3K4me3 in 
association with TSSs of many transcribed genes (Bernstein, Kamal et al. 2005; Kim, Barrera et 
al. 2005) (Figure 1.3). Subsequent studies of embryonic stem (ES) cell chromatin revealed 
surprisingly broad targeting of H3K4me3 to virtually all HCPs, regardless of expression state 
(Guenther, Levine et al. 2007; Mikkelsen, Ku et al. 2007). Sites of H3K4me3 were shown to be 
accompanied by other features of accessible chromatin, including histone acetylation, occupancy 
by the H3.3 histone variant and hyper-sensitivity to DNase I digestion (Goldberg, Banaszynski et 
al. ; Wang, Zang et al. 2008; Hon, Wang et al. 2009; Ernst and Kellis). Differentiated cells were 
also found to exhibit relatively broad targeting of H3K4me3 to promoters, though with specific 
and biologically-meaningful exceptions (Mikkelsen, Ku et al. 2007) (see Poised and repressed 
chromatin states, below).  
  These accessible, H3K4me3-marked regions are also hypo-methylated at the DNA level, 
as expected from their high CpG contents (Weber, Hellmann et al. 2007; Meissner, Mikkelsen et 
al. 2008). This is consistent with a general exclusivity between such activating and ‘open 
chromatin’ structures and DNA methylation. Indeed, several studies have provided evidence for 
direct antagonism between these epigenomic features. For instance, methylation of H3K4 was 
shown to preclude a physical interaction between the histone tail and DNMT3L (Ooi, Qiu et al. 
2007). Another study, in the plant Arabidopsis thaliana, reported a direct role for H2A.Z – a   18 
histone variant enriched in actively exchanging chromatin – in protecting gene promoters from 
DNA methylation. In addition to a global exclusivity between sites of H2A.Z deposition and 
DNA methylation, this study also demonstrated that deficiency of H2A.Z deposition led to 
generalized DNA hyper-methylation (Zilberman, Coleman-Derr et al. 2008). 
  What mechanisms could underlie the correspondence between these ‘open chromatin’ 
features, H3K4me3 and the GC-rich promoters? ChIP-chip studies in ES cells showed that many 
H3K4me3-marked promoters are also enriched for RNA polymerase II (RNAPII) and subject to 
transcriptional initiation (Guenther, Levine et al. 2007). This was a surprising finding given that 
a substantial fraction of the HCPs do not make productive RNA transcripts or even undergo 
elongation (see Poised and repressed chromatin states, below). It suggests that transcriptional 
initiation and H3K4me3 are tightly linked and, moreover, that initiating RNAPII substantially 
contributes to the accessible chromatin configuration potentially through interactions with 
chromatin modifiers as seen in yeast (Li, Carey et al. 2007; Shilatifard 2008). The concordance 
between H3K4me3 and HCPs may be more directly explained by physical recognition of un-
methylated CpG dinucleotides by CXXC domains in H3K4 methyltransferase complexes (Lee 
and Skalnik 2005). It was recently shown that introducing artificial, promoterless, CpG clusters 
into mouse ES cells was sufficient to recruit the Set1 complex and establish H3K4me3 
(Thomson, Skene et al.). A parallel study demonstrating targeting of an H3K36 demethylase 
complex by its CXXC domain suggests that such interactions may be general (Blackledge, Zhou 
et al. 2010). Together, these converging lines of experimental evidence suggest that 
transcriptional initiation and alternate pathways mutually reinforce a chromatin configuration 
that distinguishes this essential promoter class. 
Regardless of the relative contributions of these models, the data suggest that HCPs tend   19 
to adopt an accessible chromatin state by default, and are generally subject to a degree of 
initiation. Thus, effective regulation of HCP genes likely requires additional controls. Indeed, 
recent studies in macrophages and ES cells have documented roles for specific transcription 
factors in regulating steps downstream of initiation (Rahl, Lin et al. ; Hargreaves, Horng et al. 
2009; Ramirez-Carrozzi, Braas et al. 2009). The Smale and Medzhitov groups characterized a 
class of HCPs with constitutively active chromatin in macrophages that are basally transcribed 
by RNAPII, generating non-functional RNAs. After the macrophages were induced by 
lipopolysaccharide (LPS), the transcription factor NF-KB initiates a cascade that causes RNAPII 
to adopt a more processive form (i.e. from serine 5 to serine 2 phosphorylation on its C-terminal 
domain) and results in rapid production of functional transcripts. In ES cells, genomewide 
mapping studies revealed a key role for the transcription factor c-Myc in enhancing the ‘release’ 
of RNAPII at HCPs, and hence promoting the generation of mature transcripts. Together, these 
studies emphasize the importance and complexity of downstream steps in controlling the 
expression of genes associated with this major promoter class. 
  In marked contrast to HCPs, LCPs appear to be inactive by default (Figure 1.3). Indeed, 
most annotated LCPs lack H3K4me3 (or H3K4me2) in ES cells as well as in various 
differentiated cell types (Mikkelsen, Ku et al. 2007; Weber, Hellmann et al. 2007).The minority 
of LCPs that are marked by H3K4me3 appear to be fully expressed with RNA levels 
substantially higher than their unmarked counterparts. 
  Further biological insight into LCP regulation emerged from an analysis of chromatin 
structure changes during hematopoietic differentiation (Orford, Kharchenko et al. 2008). Orford 
et al. defined a subset of promoters that carry H3K4me2 but not H3K4me3 in hematopoietic 
progenitors. They found that this set corresponded to LCPs associated with hematopoietic cell   20 
type-specific genes that are generally inactive in the progenitors but become induced during 
differentiation. They specifically observed a switch from H3K4me2 to H3K4me3 upon induction 
of such LCPs during differentiation. These studies suggest that LCPs are subject to greater 
regulation at the level of initiation, and may be poised in certain contexts by lower degrees of 
histone methylation. Notably, genes subject to this form of regulation tend to encode terminal 
cell type-specific factors (e.g., structural proteins) as opposed to the master regulators that drive 
cell fate (e.g., developmental transcription factors). The latter have HCPs and are subject to more 
complex regulation by Polycomb complexes (see below). 
 
Poised and repressed chromatin states.  
 
  Repressed promoters also exhibit unique patterns of chromatin modifications that appear 
to reflect distinct modes of transcriptional silencing. These include H3K27me3, the proto-typical 
mark of Polycomb repressors; H3K9me3, which correlates with constitutive heterochromatin; 
and DNA methylation (Figure 1.4a). 
  Polycomb proteins are transcriptional repressors essential for maintaining tissue-specific 
gene expression programs in multi-cellular organisms (Simon and Kingston 2009). In mammals, 
a large proportion of HCPs are targeted by the main Polycomb repressive complexes, PRC1 and 
PRC2. Roughly 20% of HCPs are bound by PRC2 and marked by the associated modification, 
H3K27me3 (Boyer, Plath et al. 2006; Lee, Jenner et al. 2006; Mikkelsen, Ku et al. 2007; Pan, 
Tian et al. 2007; Zhao, Han et al. 2007; Ku, Koche et al. 2008). These promoters have been 
termed ‘bivalent’ as they also carry H3K4me3 and thus have characteristics of both activating 
and repressive chromatin (Azuara, Perry et al. 2006; Bernstein, Mikkelsen et al. 2006).    21 
 
 
Figure 1.4. “Dashboard” of histone modifications for fine-tuning genomic elements.  
In addition to enabling annotation, histone modifications may serve as ‘dials’ or ‘switches’ for 
cell type specificity. (a) At promoters, they can contribute to fine-tuning of expression levels, 
from on to poised to off, and perhaps even intermediate levels. (b) At gene bodies, they 
discriminate active and inactive conformations. In addition, exons in active genes have higher 
nucleosome occupancy, and thus more H3K36me3 and H3K79me2-modified histones, than 
introns. (c) At distal sites, they correlate with levels of enhancer activity. (d) At a global scale, 
they may confer repression of varying stabilities.  
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Bivalent, PRC2-target promoters have attracted considerable interest as a large proportion 
corresponds to developmental genes encoding transcription factors and other regulators of 
cellular state. These genes are largely inactive in pluripotent cells, but subsequently may be 
rapidly induced or stably inactivated, depending on the developmental course. It has been 
proposed that the signature chromatin configuration is instrumental for poising bivalent 
promoters for these alternate fates. Indeed, global studies of neural and hematopoietic 
progenitors indicate that bivalent chromatin tends to resolve at successive developmental stages 
in a pattern that closely matches the expression state and future potential of the corresponding 
genes (Mikkelsen, Ku et al. 2007). For example, Mohn et al. followed H3K27me3 patterns in 
gene promoters during transition of ES cells to neural progenitors and subsequently to terminal 
neurons, finding progression of HCP modifications in accordance with expression state and gene 
potential (Mohn, Weber et al. 2008). Similar patterns are also evident along the axis of 
hematopoietic differentiation, as indicated by analysis of in vivo lineages from both human and 
mouse (Adli, Zhu et al. ; Cui, Zang et al. 2009). 
  Although bivalent promoters in ES cells have very low expression levels and were 
initially found to be free from RNAPII (Mohn, Weber et al. 2008), subsequent studies have 
suggested that at least a subset do have detectable RNAPII enrichment (Guenther, Levine et al. 
2007; Stock, Giadrossi et al. 2007). This raises the possibility that initiating RNAPII contributes 
to the establishment of H3K4me3, or potentially even H3K27me3 at these loci. Still, the data 
should be interpreted with some caution. RNAPII enrichment was only detected under certain 
experimental conditions (Stock, Giadrossi et al. 2007) and, moreover, evidence for RNA 
transcription at these loci remains scarce (Seila, Calabrese et al. 2008). Other technical issues of 
possible relevance include an inherent promoter bias in some ChIP data, and heterogeneity due   23 
to partial differentiation. 
  How is PRC2 targeted to HCPs? The GC-rich sequence is likely to play an important role 
here given the extremely high correspondence between CpG islands and PRC2 binding. PRC2 
targets in ES cells can be predicted with remarkable accuracy by simply identifying CpG islands 
that lack motifs for activating transcription factors (Ku, Koche et al. 2008). A causal role for 
such sequences is supported by the finding that introduction of exogenous GC-rich sequence 
elements into ES cells is sufficient to mediate PRC2 recruitment (Mendenhall, Koche et al. 
2010). Still, the underlying mechanisms are not yet understood. Although sequence-specific 
DNA binding proteins guide PRC2 to target elements in Drosophila, analogous factors have yet 
to be demonstrated in mammals. Rather, mammalian PRC2 contains the atypical DNA binding 
proteins Aebp2 (Kim, Kang et al. 2009) and Jarid2 (Li, Margueron et al. ; Pasini, Cloos et al. ; 
Peng, Valouev et al. 2009; Shen, Kim et al. 2009). Jarid2 was recently shown to be essential for 
PRC2 function and the establishment of proper K27me3 patterns (Li, Margueron et al. ; Pasini, 
Cloos et al. ; Peng, Valouev et al. 2009; Shen, Kim et al. 2009). ChIP-seq analysis confirmed 
that Jarid2 co-localizes with PRC2 and K27me3 at GC-rich sequence elements. However, in 
vitro biochemical studies suggest that Jarid2 is a promiscuous DNA binding protein without 
particular specificity for GC-rich sequences (Kim, Kraus et al. 2003). Hence, this factor does not 
appear to fully explain PRC2 targeting. Non-coding RNAs have also emerged as intriguing 
candidates for recruitment. PRC2 has affinity for a variety of RNA classes, such as short GC-rich 
RNAs that might play a role in targeting the complex to weakly initiating HCPs (Kanhere, Viiri 
et al.). The complex can also interact with long intergenic non-coding RNAs (lincRNAs), 
including Xist and HOTAIR, both of which appear to play important roles in the localization and 
stabilization of Polycomb complexes in differentiating cells (Tsai, Manor et al. ; Zhao, Sun et al.   24 
2008). PRC2 association is further stabilized by the innate affinity of the complex for K27-
methylated H3 tails (Hansen, Bracken et al. 2008; Margueron, Justin et al. 2009). Thus, in 
contrast to Drosophila, PRC2 localization in mammals appears to be directed to GC-rich 
elements by a complex interplay between low-specificity DNA binding proteins, RNA targeting 
factors and chromatin-based stabilization. 
  The challenge of understanding Polycomb localization is further complicated by PRC1, 
an additional repressive complex that ubiquitinylates histone H2A and may also mediate 
structural compaction of chromatin (Simon and Kingston 2009). In ES cells, PRC1 associates 
with a specific subset of PRC2 targets that includes key developmental regulators and other 
genes subject to epigenetic repression during development (Ku, Koche et al. 2008). These PRC1 
targets tend to have larger CpG islands or extended GC-rich regions relative to PRC2-specific 
loci. In addition, recent studies have identified specific DNA elements with YY1 motifs capable 
of initiating PRC1-dependent silencing during development (Woo, Kharchenko et al. ; Sing, 
Pannell et al. 2009). A unifying theory for the complexes is an important goal as both PRC1 and 
PRC2 are almost certainly required for stable epigenetic gene repression (Simon and Kingston 
2009). 
  The landscape of Polycomb repression changes markedly through differentiation.  In 
addition to the progressive resolution of bivalent chromatin at specific promoters described 
above, a smaller subset of promoters is subject to de novo gain of H3K27me3 during 
development (Mohn, Weber et al. 2008). The affected genes include certain pluripotency 
regulators repressed during ES cell differentiation (Pan, Tian et al. 2007). At many loci, 
differentiation is also accompanied by dramatic spreading to yield contiguous if more diffuse 
domains of H3K27me3 (Hawkins, Hon et al.).   25 
Relatively less is known about the role of DNA methylation in HCP regulation during 
development. Hyper-methylation of individual CpG islands as well as extended genomic loci has 
been widely described in human cancer (Coolen, Stirzaker et al. ; Jones and Baylin 2007). Yet 
genome-scale studies suggest that most CpG islands remain largely un-methylated during normal 
development (Meissner, Mikkelsen et al. 2008; Mohn, Weber et al. 2008). Still, a closer look at 
the DNA methylation pattern of HCPs shows that even though the CpG islands are un-
methylated, their ‘shores’ – sequences up to 2kb distant from the CpG islands – frequently 
become methylated in tissue-specific patterns (Irizarry, Ladd-Acosta et al. 2009). CpG island 
shores may also be conserved between human and mouse, and when methylated correlate to gene 
silencing in a tissue specific manner. Although the functionality of the shores remains 
controversial, global reduction of DNA methylation by a small molecule (5-AZA-c) or by 
knockout of DNA methyltransferases shows concurrent activation of these genes. More broadly, 
genome-scale and genomewide analysis of DNA methylation patterns have provided insight into 
ES cell regulation (Lister, Pelizzola et al. 2009), hematopoietic differentiation (Ji, Ehrlich et al.), 
and epigenetic roadblocks to cellular reprogramming (Mikkelsen, Hanna et al. 2008). 
   Up to 80% of LCPs are DNA methylated in ES cells (Fouse, Shen et al. 2008; Meissner, 
Mikkelsen et al. 2008). The functional consequence of the DNA methylation remains unclear – 
the relative paucity of CpG dinculeotides in these regions suggests that the impact may be slight. 
Interestingly, however, inactive LCPs are frequently located within extended regions of 
H3K27me3 or H3K9me3 that may reflect large-scale sequestration of inactive genomic regions, 
and thereby hold potential for contextual repression of chromosomal regions (see H3K9me3 and 
lamina-associated domains, below). 
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Gene bodies.  
 
Mammalian genes are characterized by large numbers of exons in an expanse of introns. 
In many cases, alternative splicing provides an additional layer of complexity and regulation 
(Nilsen and Graveley). Recent studies suggest that chromatin patterns can distinguish primary 
transcripts and exons, and may even play a role in determining splicing patterns. Major marks 
seen in transcribed regions include H3K36me3 (Barski, Cuddapah et al. 2007; Mikkelsen, Ku et 
al. 2007) and H3K79me2 (Li, Carey et al. 2007) (Figure 1.4b). Comparative analyses of 
H3K36me3 with expression and splicing data reveal several emerging trends. First, H3K36me3 
levels correlate with levels of gene expression (Barski, Cuddapah et al. 2007; Mikkelsen, Ku et 
al. 2007). This likely reflects interactions between elongating RNAPII and the corresponding 
methyltransferases (Li, Carey et al. 2007). 
  Recent studies have noted that expressed exons, as opposed to introns, have particularly 
strong enrichment for H3K36me3 (Andersson, Enroth et al. 2009; Kolasinska-Zwierz, Down et 
al. 2009; Schwartz, Meshorer et al. 2009). They may also exhibit modest enrichment for 
H2BK5me1, H4K20me1, and H3K79me1 (Ernst and Kellis). Subsequent studies have indicated 
that the observed enrichments for histone marks likely reflect preferential occupancy and 
positioning of nucleosomes over exons (Schwartz, Meshorer et al. 2009; Tilgner, Nikolaou et al. 
2009) (Figure 1.4b). Specifically, computational analyses in the latter studies suggest that this 
higher abundance of nucleosomes might account for the observed exonic H3K36me3 
enrichment. The authors of these studies speculated that positioned nucleosomes at exons might 
enhance splicing by acting as ‘speed bumps’ to slow RNAPII. According to this model, the   27 
splicing machinery is recruited during transcription, and an increased RNAPII occupancy time 
might translate into improved recognition of splicing signals (Kornblihtt, Schor et al. 2009). 
A recent study by the Misteli group more directly linked histone modifications at gene 
bodies with the splicing machinery (Luco, Pan et al.). These authors studied the alternatively 
spliced gene, FGFR2. They found that histone modifications across the gene vary between cell 
types. Specifically, they observed distinct patterns of H3K36me3, H3K4me3, H3K4me1 and 
H3K27me3 over FGFR2 in epithelial cells and mesenchymal cells, which produce different 
splice forms. Remarkably, by modulating the levels of H3K36me3 and H3K4me3, the authors 
were able to influence the splicing patterns. They suggest a model in which histone marks are 
read by the splicing machinery via the histone-tail binding protein MRG15 and the splicing 
regulator PTB. Interestingly, if these histone patterns are general signatures of alternatively 
spliced exons, a comparison of genomewide maps of these marks in different cell types may 
reveal global maps of alternative splicing events. Regardless, the robust enrichment of modified 
nucleosomes at exons suggests that a link between histone modifications and splicing may be a 
general phenomenon.  
 
Enhancers.  
 
Enhancers are DNA elements that recruit transcription factors, RNAPII, and chromatin 
regulators to positively influence transcription at distal promoters (Visel, Rubin et al. 2009). 
Histone modification profiles have proven to be particularly useful for identifying enhancer 
elements in unbiased fashion. In addition to specific histone modifications, these elements are 
preferentially occupied by sequence-specific DNA binding proteins (Birney,   28 
Stamatoyannopoulos et al. 2007) and coactivators such as p300 (Visel, Blow et al. 2009) (Figure 
1.2). By observing the histone modifications at distal p300-binding sites, Heintzman et al. 
identified relative H3K4me1 enrichment and relative H3K4me3 depletion as a chromatin 
signature of enhancers in human cells (Heintzman, Stuart et al. 2007). The group used this 
signature to predict over 55,000 candidate enhancers in five human cell types, including K562 
and HeLa (Heintzman, Hon et al. 2009). Remarkably, the chromatin patterns at enhancers were 
much more variable and cell type-specific than chromatin patterns at promoters or insulators. 
This study suggested a critical role for enhancers in controlling the level and timing of 
expression in a cell type-specific manner and highlights the power of histone modification 
profiling for capturing diverse functional elements. 
Despite the fruitful application of a histone modification signature to predict enhancers, 
the mechanism by which H3K4me1 is established at these sites remains unknown. Integrative 
analyses suggest that enhancers also share enrichment for H3K27 acetylation, H2BK5me1, 
H3K4me2, H3K9me1, H3K27me1, and H3K36me1, suggesting redundancy in the histone marks 
(Hon, Wang et al. 2009). This may be an indication of generalized accessibility or chromatin 
dynamics at these sites. It may also reflect physical proximity of the enhancer elements to 
activating chromatin machinery at their target promoters, through looping interactions (Visel, 
Rubin et al. 2009). The chromatin patterns at enhancers may also be actively fine-tuned as 
different patterns of acetylation and H2A.Z deposition correlate with differences in downstream 
gene expression levels (Ernst and Kellis) (Figure 1.4c).  
Support for a more direct interaction between enhancers and the transcriptional 
machinery emerged from a recent genomewide study that mapped p300 and H3K4me1 in mouse 
cortical neurons. Kim et al. found that RNAPII interacts with many active enhancers identified   29 
by the chromatin patterns in these cells and transcribes bi-directional short (<2kb) non-coding 
RNAs, termed eRNAs (Kim, Hemberg et al.). The expression levels of eRNAs correlate with the 
proximal gene activity, and eRNA synthesis appeared to require interaction with the relevant 
promoter. The exact function of these eRNAs is not understood, but similar findings also 
emerged from a study of enhancer elements in macrophages (De Santa, Barozzi et al. 2010). 
Transcription of eRNAs could be needed to maintain open chromatin at the enhancer region but, 
alternatively, may be a by-product of the chromatin configuration or looping. 
   
Insulators and boundary elements.  
 
Insulators are DNA elements that block enhancer activities (Phillips and Corces 2009) 
(Figure 1.2). They are likely related to boundary elements defined by their capacity to prevent 
heterochromatin spreading. In mammals, the CTCF protein has been both implicated in these 
two processes, and in inter- and intra-chromosomal organization. CTCF has been profiled 
genomewide in several human cell types, revealing tens of thousands of binding sites in primary 
human fibroblasts, CD4+ T cells, and HeLa cells (Barski, Cuddapah et al. 2007; Kim, Abdullaev 
et al. 2007; Heintzman, Hon et al. 2009). These studies come to the consensus that the majority 
of CTCF binding sites share a common motif and are relatively invariant across different cell 
types. The CTCF binding sites also show modest enrichment for the histone variant H2A.Z, but 
surprisingly, vary widely in terms of other accompanying histone modifications (Hon, Wang et 
al. 2009; Ernst and Kellis). Recent models suggest that CTCF, most likely in association with 
cohesion (Wendt, Yoshida et al. 2008), stabilizes long-range DNA interactions and chromatin 
loops. In this way, the factor is thought to be instrumental in establishing a defined three-  30 
dimensional genome structure and partitioning distinct chromatin domains (Phillips and Corces 
2009). 
   
HIGHER-ORDER CHROMATIN ORGANIZATION 
 
As cells differentiate from a totipotent to a specialized committed state, a high percentage 
of their genome must be stably repressed. In this regard, chromatin regulators and histone 
modifications appear to work in conjunction with other mechanisms to silence broad genomic 
regions. There are several known modes of large-scale repression that correlate with megabase 
(Mb) domains of H3K9me3 and H3K27me3 and likely reflect specialized higher-order 
chromatin structures within the nucleus (Figure 1.4d, Figure 1.5). 
 
H3K9me3 and lamina-associated domains.  
 
The nuclear lamina is thought to bind and silence large regions of heterochromatin. Two 
studies probing for distinct genomic features identified similar sets of domains enriched for 
H3K9 methylation and lamina contact (Guelen, Pagie et al. 2008; Wen, Wu et al. 2009). Guelen 
et al. globally mapped the interaction between the genome and nuclear lamina in human 
fibroblasts using DamID. These authors observed two discrete chromatin environments: lamina-
associated domains (LADs), and regions outside LADs. Both regions were on the order of 0.1 – 
10 Mb in size. LADs were found to have low gene density, low transcriptional activity and a 
paucity of active chromatin modifications.  
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Figure 1.5. Histone modification signatures associated with features in the mammalian cell 
nucleus.  
Signature histone modifications correlate with various nuclear features, although they may not 
have a one-to-one correspondence. Chromatin with generally active modifications (green dots) 
often replicates early, while chromatin with generally repressive modifications (purple dots) 
replicates late. Regions enriched for active modifications (blue dots) may converge into 
transcription factories (TF). Blocks of H3K27me3 (red dots) may form Polycomb bodies (Pc), 
while diffuse domains marked by H3K9me3 (orange dots) appear to contact the nuclear lamina.   32 
Although the nuclear lamina had previously been associated with inactivity, these studies defined 
for the first time their locations, extents and correlated chromatin patterns. Remarkably, tethering 
experiments show that interaction with the nuclear lamina is not only correlative but is also 
causal in reducing gene expression (Finlan, Sproul et al. 2008; Kumaran and Spector 2008; 
Reddy, Zullo et al. 2008). 
 Wen et al. identified a similar set of genomic domains by analyzing genomewide maps 
of H3K9me2 in differentiated and undifferentiated cells (Wen, Wu et al. 2009). They found large 
and diffuse regions of K9 methylation that cover up to 4.9 Mb and collectively represent up to 
46% of the genome, which they termed LOCKs. These investigators also showed that LOCKs 
are conserved between human and mouse, and that the H3K9me2 was dependent on the G9a 
H3K9 methyltransferase. Furthermore, a close relationship between LOCKs and LADs was 
indicated by a striking overlap of 82% between placental LOCKs and LADs found in fibroblasts. 
Thus, genomic regions diffusely marked by H3K9 methylation seem to be in contact with the 
nuclear lamina; these findings have prompted a model in which chromatin is partitioned into 
distinct environments for each cell type (Figure 1.4d). It was initially proposed that LOCKs are 
relatively scarce in ES cells as few such chromatin domains could be detected. However, 
whether this reflects a true distinction in modification patterns between cell types, or a detection 
bias, has been questioned (Filion and van Steensel 2010). The nature of these compartments 
remains an area of active investigation as these structures could play a critical role in 
sequestering non-utilized regions of the genome, and thereby reducing the effective ‘search-
space’ for gene regulatory machinery. 
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H3K27me3 blocks and Polycomb bodies.  
 
Genomewide histone modification maps have also revealed large blocks of H3K27me3 in 
differentiated cells. An appreciation of these domains relied on new algorithms for identifying 
broad regions, rather than sharp peaks, of enrichment, as two recent studies illustrate. Pauler et 
al. used an algorithm called broad local enrichments (BLOCs) to identify H3K27me3 blocks that 
average 43 kb and overlap silent genes and intergenic regions (Pauler, Sloane et al. 2009). They 
find this pattern in numerous ChIP-chip and ChIP-seq datasets, and suggest that this is a common 
feature of H3K27me3 in differentiated cell types. The authors speculate that these H3K27me3 
blocks may relate to Giemsa bands, as they observe alternating chromatin patterns along 
chromosomes. Hawkins et al. used ChromaBlocks to find similar H3K27me3 blocks in IMR90 
fibroblasts, and further characterize their dynamics during differentiation (Hawkins, Hon et al.). 
This study suggests that these repressive domains are often seeded in ES cells and expand in 
differentiated cell types, apparently to confer cell type-specific repression (Figure 1.4d). As these 
domains have only recently been observed, little is known about their establishment or functional 
consequences. It is tempting to consider that, like H3K9me2 domains, H3K27me3 blocks mark 
distinct nuclear structures or regions. They potentially correspond to Polycomb bodies, discrete 
foci of silenced genes that have been observed by imaging and in situ hybridization in fly and 
human cells (Sexton, Schober et al. 2007). Although there is no data yet directly tying 
H3K27me3 blocks to these structures, there is indirect evidence linking the mark to compacted 
chromatin. H3K27me3 can promote recruitment of PRC1 (Simon and Kingston 2009). In turn, 
PRC1 may be required to maintain chromatin compaction at the Hox loci in ES cells (Eskeland, 
Leeb et al.). Together, these studies support connections between Polycomb regulation, histone   34 
modifications and chromatin compartmentalization that promise to be an exciting area for further 
investigation. 
 
Replication time zones.  
 
In addition to delineating particular genomic elements, chromatin patterns gleaned 
through mapping studies also appear to relate to DNA replication timing (Figure 1.5). Rather 
than executing replication in a random fashion, the genome is divided into distinct replication 
time zones that average 1 Mb in size and tend to undergo DNA synthesis at coordinated times 
during S-phase (Goren and Cedar 2003). Plasmid injection experiments initially suggested a tight 
link between replication timing and histone H3 and H4 acetylation: regardless of sequence, a 
DNA fragment that is introduced into a cell in early S will be wrapped around acetylated 
histones, while the same fragment will be associated with deacetylated histones when injected in 
late S (Zhang, Xu et al. 2002). Genomewide profiling of replication timing in mouse and human 
cells revealed a correlation between replication domains and chromatin structure (Ryba, Hiratani 
et al. ; Karnani, Taylor et al. 2007). Early replicating zones associate with H3K4me1/2/3, H3K9 
and H3K27 acetylation, and H3K36me3 and H4K20me1, while late replicating zones mostly 
correlate with H3K9me2, and to a lesser degree with H3K9me3 (Ryba, Hiratani et al.). More 
than simply correlative, subsequent studies have shown that the histone acetylation patterns 
directly influence the timing at which origins initiate replication (‘fire’) during S-phase in both 
yeast and mouse models (Vogelauer, Rubbi et al. 2002; Goren, Tabib et al. 2008). Of note, 
bivalent chromatin replicates early, despite being transcriptionally inactive, potentially reflecting 
an accessible and poised character (Azuara, Perry et al. 2006). Notably, boundaries between   35 
replicating zones are also associated with a signature modification pattern – namely, peaks of 
H3K4me1/2/3, H3K27ac and H3K36me3. It has been speculated that the ‘active’ histone 
modifications might serve as functional boundary elements that block spreading of late-
replicating heterochromatin. Together, the studies presented above illustrate global 
correspondences between histone modification patterns, replication timing and higher-order 
nuclear structures (Figure 1.5). 
 
PERSPECTIVES AND FUTURE CHALLENGES 
 
The implications of the growing panel of genomewide histone modification maps are 
several. At the level of the primary chromatin structure, the data suggest that histone 
modifications are indicative of functional genomic elements, gene expression, splicing patterns, 
and modes of repression. Together with perturbation studies on the mechanisms that write and 
read these marks, this insight may enable us to better understand and predict how normal or 
diseased cell types utilize and regulate their genomes. Additionally, these maps promote an 
appreciation of the three-dimensional organization of the genome. During the last few years, 
more and more pieces of the nuclear architecture ‘jigsaw-puzzle’ have been revealed. As we 
have discussed, histone modifications are intimately tied to large-scale repressive domains like 
LADs and Polycomb bodies, and broad patterns of replication time zones. Together with 
ongoing studies of additional structures such as transcription factories and nucleolus-associated 
domains (Nemeth, Conesa et al. ; Schoenfelder, Sexton et al. 2010), these findings are building a 
better understanding of the architecture of chromatin within the nucleus.   36 
  Several recent technological advances provide direction towards a molecular 
understanding of the spatial organization of chromatin. Lieberman-Aiden et al. scaled the 
chromosome conformation capture (3C) assay for unbiased genomewide identification of 
chromatin interactions (Hi-C) (Lieberman-Aiden, van Berkum et al. 2009). This approach 
revealed distinct spatial compartments distinguished by their degree of openness, but was limited 
in terms of the resolution with which it could distinguish interactions and compartmentalization. 
Fullwood et al. scaled the technology of a related approach that also incorporates an 
immunoprecipitation step (ChIA-PET) (Fullwood, Liu et al. 2009). They focused on the 
interaction network bound by oestrogen receptor α, and note numerous cases of chromatin 
looping for coordinated transcriptional regulation. Another important area of technology 
development relates to miniaturization and increasing the sensitivity of the assays so they may be 
compatible with small samples or even individual cells (Adli, Zhu et al. 2010; Goren, Ozsolak et 
al. 2010). High-resolution imaging approaches may also be instrumental in this regard. 
Combined with more powerful and integrative computational algorithms, such tools should 
ultimately enable every genomic region within a living cell to be tracked across differentiation, 
development, and disease. 
  Despite our increasing knowledge on various aspects of chromatin structure, we are still 
far from understanding the determinants of this structure. Relatively little is known about the 
complexes that introduce and maintain histone modification patterns. Even less is known about 
the way specific modification signatures, or ‘states,’ are read. How combinatorial options of 
chromatin ‘writer’ and ‘reader’ proteins facilitate more sophisticated and robust regulation of 
gene expression and genome function remains a key area of investigation. Detailed knowledge of 
global chromatin architecture along with these regulators represents a critical step towards   37 
understanding how genetic, epigenetic, and environmental/stochastic factors drive context-
specific genome regulation.  
  This era is an exciting time in biology, in which new genomic tools are validating or 
refuting dogmas developed through gene-specific analysis, as well as illuminating entirely 
unexpected principles. The pace of change is accelerating thanks to remarkable advances in 
DNA sequencing, increasing availability of epigenomic data in the public domain from NIH and 
international projects (Birney, Stamatoyannopoulos et al. 2007; Bernstein, Stamatoyannopoulos 
et al. 2010; Satterlee, Schubeler et al. 2010), and the rapid dissemination of these technologies 
into individual research laboratories. By changing our focus from ‘gene-centered’ to 
‘genomewide’, such approaches hold much promise to enhance our understanding of genome 
architecture and its consequences on gene regulation, genome stability, cell phenotype, and 
organismal physiology in both health and disease. 
 
GLOSSARY 
 
DNaseI-seq: A method that distinguishes open chromatin regions based on their hypersensitivity 
to DNase I digestion. Sequencing these genomic fragments can generate genomewide maps of 
chromatin accessibility. 
FAIRE-seq: “Formaldehyde Assisted Isolation of Regulatory Elements” followed by sequencing 
exploits the solubility of open chromatin in the aqueous phase during phenol:chloroform 
extraction to generate genomewide maps of soluble chromatin. 
Sono-seq: A technique that relies on the increased sonication efficiency of open crosslinked 
chromatin to identify regions of increased accessibility genomewide.   38 
MNase-seq: A method that distinguishes nucleosome positioning based on the ability of 
nucleosomes to protect associated DNA from digestion by micrococcal nuclease. Protected 
fragments are sequenced to produce genomewide maps of nucleosome localization. 
CATCH-IT: “Covalent Attachment of Tags to Capture Histones and Identify Turnover” is an 
assay for measuring nucleosome turnover kinetics genomewide by metabolically labeling 
histones and profiling labeled DNA by microarray. 
ChIP-seq: A method for mapping the distribution of histone modifications and chromatin-
associated proteins genomewide that relies on immunoprecipitation with antibodies to modified 
histones or other chromatin proteins. The enriched DNA is sequenced to create genomewide 
profiles. 
Hidden Markov Model: An HMM is a statistical model in which internal states are not visible 
but the outputs of these states are, and these outputs can be used to infer the internal states. This 
model can be used to determine biologically-relevant states from ChIP-seq datasets.  
CpG islands: Genomic regions that are enriched for CpG dinucleotides, often occurring near 
constitutively active promoters. Mammalian genomes are otherwise depleted of CpGs due to 
preferential deamination of methylated cytosines. 
DamID: A method for mapping the distribution of chromatin-associated proteins by fusing a 
protein of interest with E.coli DNA adenine methyltransferase (Dam), which methylates 
adenines proximal to the protein’s binding sites, thus circumventing the need for antibodies. 
Giemsa bands: Also known as G-bands, a characteristic banding pattern obtained by treating 
chromosomes with Giemsa stain. The intensity of Giemsa staining is correlated with genomic 
features. For instance, dark Giemsa bands usually are AT rich, have low gene density, and have 
higher densities of repeat elements.   39 
Polycomb bodies: Discrete nuclear foci containing Polycomb proteins and their silenced target 
genes. These have been observed in both D. melanogaster and human cells by in situ 
hybridization. 
3C: “Chromosome Conformation Capture” is a method to map chromosome interactions locally. 
It relies on increased frequency of intramolecular ligation between fragments in close three-
dimensional proximity within the nucleus. 
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ABSTRACT 
 
  Polycomb proteins are epigenetic regulators that localize to developmental loci in the 
early embryo where they mediate lineage-specific gene repression. In Drosophila, these 
repressors are recruited to sequence elements by DNA binding proteins associated with 
Polycomb repressive complex 2 (PRC2). However, the sequences that recruit PRC2 in 
mammalian cells have remained obscure. To address this, we integrated a series of engineered 
bacterial artificial chromosomes into embryonic stem (ES) cells and examined their chromatin. 
We found that a 44 kb region corresponding to the Zfpm2 locus initiates de novo recruitment of 
PRC2. We then pinpointed a CpG island within this locus as both necessary and sufficient for 
PRC2 recruitment. We found that YY1 binding was not necessary for this recruitment, and that 
genomewide YY1 localization does not correlate with PRC1 or PRC2 localization. Our findings 
demonstrate a causal role for GC-rich sequences in PRC2 recruitment, and suggest that YY1 is 
not directly involved in PRC2 recruitment in mammalian genomes.  
 
AUTHOR SUMMARY 
 
  Key developmental genes are precisely turned on or off during development, thus 
creating a complex, multi-tissue embryo. The mechanism that keeps genes off, or repressed, is 
crucial to proper development. In embryonic stem cells, Polycomb repressive complex 2 (PRC2) 
is recruited to the promoters of these developmental genes, and helps to maintain repression in 
the appropriate tissues through development. How PRC2 is initially recruited to these genes in 
the early embryo remains elusive. Here we experimentally demonstrate that stretches of GC-rich   54 
DNA, termed CpG islands, can initiate recruitment of PRC2 in embryonic stem cells. This 
supports a model where inactive GC-rich DNA can itself suffice to recruit PRC2 even in the 
absence of more complex DNA sequence motifs, such as YY1.  
 
INTRODUCTION 
 
  Polycomb proteins are epigenetic regulators required for proper gene expression 
patterning in metazoans. The proteins reside in two main complexes, termed Polycomb 
repressive complex 1 and 2 (PRC1 and PRC2). PRC2 catalyzes histone H3 lysine 27 tri-
methylation (K27me3), while PRC1 catalyzes histone H2A ubiquitination and mediates 
chromatin compaction (Schwartz and Pirrotta 2007; Schuettengruber, Ganapathi et al. 2009). 
PRC1 and PRC2 are initially recruited to target loci in the early embryo where they subsequently 
mediate lineage-specific gene repression. In embryonic stem (ES) cells, the complexes localize 
to thousands of genomic sites, including many developmental loci (Boyer, Plath et al. 2006; Lee, 
Jenner et al. 2006; Ku, Koche et al. 2008). These target loci are not yet stably repressed, but 
instead maintain a “bivalent” chromatin state, with their chromatin enriched for the activating 
histone mark, H3 lysine 4 tri-methylation (K4me3), together with the repressive K27me3 
(Azuara, Perry et al. 2006; Bernstein, Mikkelsen et al. 2006). In the absence of transcriptional 
induction, PRC1 and PRC2 remain at target loci and mediate repression through differentiation. 
The mechanisms that underlie stable association of the complexes remain poorly understood, but 
likely involve interactions with the modified histones (Cao, Wang et al. 2002; Czermin, Melfi et 
al. 2002; Kuzmichev, Nishioka et al. 2002; Hansen, Bracken et al. 2008; Margueron, Justin et al. 
2009).   55 
  Proper localization of PRC1 and PRC2 in the pluripotent genome is central to the 
complex developmental regulation orchestrated by these factors. However, the sequence 
determinants that underlie this initial landscape remain obscure. Polycomb recruitment is best 
understood in Drosophila, where sequence elements termed Polycomb response elements (PREs) 
are able to direct these repressors to exogenous locations (Ringrose and Paro 2007). PREs 
contain clusters of motifs recognized by DNA binding proteins such as Pho, Zeste and GAGA, 
which in turn recruit PRC2 (Simon, Chiang et al. 1993; Wang, Brown et al. 2004; Dejardin, 
Rappailles et al. 2005; Tolhuis, de Wit et al. 2006). Despite extensive study, neither PRE 
sequence motifs nor binding profiles of PRC2-associated DNA binding proteins are sufficient to 
fully predict PRC2 localization in the Drosophila genome (Negre, Hennetin et al. 2006; 
Schwartz, Kahn et al. 2006; Tolhuis, de Wit et al. 2006; Schuettengruber, Ganapathi et al. 2009).  
  While protein homologs of PRC1 and PRC2 are conserved in mammals, DNA sequence 
homologs of Drosophila PREs appear to be lacking in mammalian genomes (Ringrose and Paro 
2007). Moreover, it remains controversial whether the DNA binding proteins associated with 
PRC2 in Drosophila have functional homologs in mammals. The most compelling candidate has 
been YY1, a Pho homolog that rescues gene silencing when introduced into Pho-deficient 
Drosophila embryos (Atchison, Ghias et al. 2003). YY1 has been implicated in PRC2-dependent 
silencing of tumor suppressor genes in human cancer cells (Ko, Hsu et al. 2008). However, this 
transcription factor has also been linked to numerous other functions, including imprinting, DNA 
methylation, B-cell development and ribosomal protein gene transcription (Sui, Affar el et al. 
2004; Liu, Schmidt-Supprian et al. 2007; Xi, Yu et al. 2007; Kim, Kang et al. 2009; Yue, Kang 
et al. 2009). 
  Recently, researchers identified two DNA sequence elements able to confer Polycomb   56 
repression in mammalian cells. Sing and colleagues identified a murine PRE-like element that 
regulates the MafB gene during neural development (Sing, Pannell et al. 2009). These 
investigators defined a critical 1.5 kb sequence element that is able to recruit PRC1, but not 
PRC2 in a transgenic cell assay. Woo and colleagues identified a 1.8 kb region of the human 
HoxD cluster that recruits both PRC1 and PRC2 and represses a reporter construct in 
mesenchymal tissues (Woo, Kharchenko et al.). Both groups note that their respective PRE 
regions contain YY1 motifs. Mutation of the YY1 sites in the HoxD PRE resulted in loss of 
PRC1 binding and partial loss of repression, while comparatively, deletion of a separate highly 
conserved region from this element completely abrogated PRC1 and PRC2 binding as well as 
repression (Woo, Kharchenko et al.).  
  In addition to these locus-specific investigations, genomic studies have sought to define 
PRC2 targets and determinants in a systematic fashion. The Ezh2 and Suz12 subunits have been 
mapped in mouse and human ES cells by chromatin immunoprecipitation and microarrays 
(ChIP-chip) or high-throughput sequencing (ChIP-Seq) (Boyer, Plath et al. 2006; Bracken, 
Dietrich et al. 2006; Lee, Jenner et al. 2006; Ku, Koche et al. 2008). Such studies have 
highlighted global correlations between PRC2 targets and CpG islands (Ku, Koche et al. 2008; 
Mohn, Weber et al. 2008) as well as highly-conserved genomic loci (Bernstein, Mikkelsen et al. 
2006; Lee, Jenner et al. 2006; Tanay, O'Donnell et al. 2007). Recently, Jarid2 has been shown to 
associate with PRC2 and to be required for proper genomewide localization of the complex (Li, 
Margueron et al. ; Pasini, Cloos et al. ; Peng, Valouev et al. 2009; Shen, Kim et al. 2009). 
Intriguingly, Jarid2 contains an ARID and a Zinc-finger DNA-binding domain. However, it is 
unclear how Jarid2 could account for PRC2 targeting given the lack of sequence specificity and 
the low affinity of its DNA binding domains (Li, Margueron et al. ; Kim, Kraus et al. 2003). In   57 
summary, a variety of sequence elements including CpG islands, conserved elements and YY1 
motifs have been implicated in Polycomb targeting in mammalian cells. Causality has only been 
demonstrated in two specific instances and a unifying view of the determinants of Polycomb 
recruitment remains elusive. 
  Here we present the identification of multiple sequence elements capable of recruiting 
PRC2 in mammalian ES cells. This was achieved through an experimental approach in which 
engineered bacterial artificial chromosomes (BACs) were stably integrated into the ES cell 
genome. Evaluation of a series of modified BACs specifically identified a 1.7 kb DNA fragment 
that is both necessary and sufficient for PRC2 recruitment. The fragment does not share 
sequence characteristics of Drosophila PREs and lacks YY1 binding sites, but rather corresponds 
to an annotated CpG island. Based on this result and a genomewide analysis of PRC2 target 
sequences, we propose that GC-rich sequence elements, rather than YY1, play causal roles in the 
initial localization of PRC2 and the subsequent coordination of epigenetic controls during 
mammalian development.  
 
RESULTS 
 
Recruitment of Polycomb repressors to a Bacterial Artificial Chromosome Integrated into 
ES Cells 
 
  To identify DNA sequences capable of recruiting Polycomb repressors in mammalian 
cells, we engineered human BACs that correspond to genomic regions bound by these proteins in 
human ES cells (Figure 2.1).   58 
 
Figure 2.1. Schematic of Transgenic Chromatin Assay 
A schematic of the transgenic chromatin assay that was used to examine the role of DNA 
sequence in determining histone modification patterns in embryonic stem cells.   59 
  We initially targeted a region of the human Zfpm2 (hZfpm2) locus, which encodes a 
developmental transcription factor involved in heart and gonad development (Tevosian, Albrecht 
et al. 2002). In ES cells, the endogenous locus recruits PRC1 and PRC2, and is enriched for the 
bivalent histone modifications, K4me3 and K27me3 (Figure 2.2A). We used recombineering to 
engineer a 44 kb BAC containing this locus and a neomycin selection marker. The modified 
BAC was electroporated into mouse ES cells, and individual transgenic ES cell colonies 
containing the full length BAC were expanded (Figure 2.1). 
  We used ChIP and quantitative PCR (ChIP-qPCR) with human specific primers to 
examine the chromatin state of the newly incorporated hZfpm2 locus. This analysis revealed 
strong enrichment for K27me3 and K4me3 (Figure 2.2B). In addition, we explicitly tested for 
direct binding of the Polycomb repressive complexes using antibody against the PRC1 subunit, 
Ring1B, or the PRC2 subunit, Ezh2. We detected robust enrichment for both complexes in the 
vicinity of the hZfpm2 gene promoter (Figure 2.2B). To confirm this result and eliminate the 
possibility of integration site effects, we tested two additional transgenic hZfpm2 ES cell clones 
with unique integration sites, and in both cases, we observed a bivalent chromatin state 
analogous to the endogenous loci. These results suggest that DNA sequence is sufficient to 
initiate de novo recruitment of Polycomb in ES cells.  
 
Distinguishing Polycomb Recruiting Sequences in the Zfpm2 BAC 
 
  We next sought to define the sequences within the hZfpm2 BAC required for recruitment 
of Polycomb repressors. First, we re-engineered the 44 kb hZfpm2 BAC to remove 20 kb of 
flanking sequences that contained distal non-coding conserved sequence elements (Figure 2.2A).   60 
 
 
 
 
 
 
Figure 2.2. Recruitment of Polycomb Repressors to a BAC Integrated into ES Cells  
(A) ChIP-Seq tracks depict enrichment of K27me3 (the modification catalyzed by PRC2), Ezh2 
(the enzymatic component of PRC2), and K4me3 across the endogenous hZfpm2 locus in human 
ES cells. Primers and constructs used in this study are indicated below the gene track. (B) BAC 
constructs from (A) containing the hZfpm2 locus were stably integrated into mouse ES cells. 
ChIP-qPCR enrichments are shown for K4me3, K27me3, Ezh2, and the PRC1 component 
Ring1b across the locus. The integrated locus adopts a ‘bivalent’ chromatin state with K27me3 
and K4me3 in all constructs except the ΔCGI BAC. The locations of PCR amplicons are 
designated on the horizontal axis. Error bars show standard error of the mean (SEM) for n=3 (44 
kb) or n=2 (22 kb; ΔCGI) biological replicates. 
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Figure 2.2 (Continued).  62 
When we integrated the resulting 22 kb construct into ES cells we found that it robustly enriches 
for PRC1, PRC2, K4me3 and K27me3 (Figure 2.2B). Hence, these particular distal elements do 
not appear to be required for the recruitment of the complexes. Next, we considered the necessity 
of the CpG island which corresponds to the peak of Ezh2 enrichment in ChIP-Seq profiles 
(Figure 2.2A). We excised a 1.7 kb fragment containing the CpG island, and integrated the 
resulting BAC (ΔCGI) into ES cells. The ΔCGI BAC failed to recruit PRC1 or PRC2, and 
showed significantly reduced K27me3 levels relative to the other constructs (Figure 2.2B). This 
suggests that the CpG island is essential for recruitment of Polycomb proteins to the hZfpm2 
locus. 
 
A 1.7 kb CpG island is Sufficient to Recruit PRC2 to an Exogenous Locus 
 
  We next asked whether the hZfpm2 CpG island is sufficient to recruit Polycomb 
repressors to an exogenous locus. To test this, we selected an unremarkable gene desert region 
on human chromosome 1 that shows no enrichment for PRC1, PRC2 or K27me3 in ES Cells 
(Figure 2.3A). We also verified that the gene desert BAC alone does not show any enrichment 
for K27me3 or Ezh2 when integrated into ES cells (Figure 2.3B). Using recombineering, we 
inserted the 1.7 kb sequence that corresponds to the hZfpm2 CpG island into the gene desert 
BAC. The resulting construct was integrated into mouse ES cells and three independent clones 
were evaluated. ChIP-qPCR analysis revealed strong enrichment for K27me3, K4me3 and PRC2 
over the inserted CpG island (Figure 2.3C). In contrast, we observed relatively little enrichment 
for the PRC1 subunit Ring1B (Figure 2.3C). We confirmed the specificity of these enrichments 
with primers that span the boundary between the insertion and adjacent gene desert sequence.    63 
 
 
Figure 2.3. A 1.7 kb GC-rich Sequence Element is Sufficient to Recruit PRC2 
(A) ChIP-Seq tracks show no enrichment for K4me3, K27me3 or Ezh2 in human ES cells across 
the gene desert region. For comparison a nearby locus is shown. The recombineering site and 
primers used are indicated below the tracks. (B) The gene desert BAC shows no enrichment of 
K4me3, K27me3 or PRC2 upon integration in mouse ES cells. (C) The hZfpm2 CpG island is 
depicted at the site of insertion into the gene desert BAC, along with the corresponding GC 
percentage (42% indicates genome average) and primers used for qPCR. Underlying plots 
represent ChIP-qPCR enrichment of K4me3, K27me3, PRC2 (Ezh2), and PRC1 (Ring1b) at the 
indicated sites (n=2 biological replicates). (D) The Zfpm2 Gene Desert BAC shows no 
enrichment of YY1, in contrast to the promoter of Rpl13a. Error bars equal to SEM (n = 2).   64 
Notably, K27me3 enrichment was detected across the gene desert locus up to 2.5 kb from the 
inserted CpG island (Figure 2.3C). This indicates that the localized CpG island can initiate 
K27me3 that then spreads into adjacent sequence. Lastly we found no YY1 enrichment across 
the CpG island by ChIP-qPCR (Figure 2.3D). Together, these data suggest that the hZfpm2 CpG 
island contains the necessary signals for PRC2 recruitment but is insufficient to confer robust 
PRC1 association, and that YY1 binding is not necessary for PRC2 recruitment.  
 
YY1 is not Directly Involved in PRC2 Recruitment in Mammalian ES Cells 
   
  The functionality of a CpG island in PRC2 recruitment is consistent with prior 
observations that a majority of PRC2 sites in ES cells correspond to CpG islands (Lee, Jenner et 
al. 2006; Ku, Koche et al. 2008). We therefore considered whether specific signals within the 
Zfpm2 CpG island might underlie its capacity to recruit PRC2.  
  First, we searched for sequence motifs analogous to the PREs that recruit PRC2 in 
Drosophila. We focused on motifs recognized by YY1, the nearest mammalian homolog of the 
Drosophila recruitment proteins. Notably, both of the recently described mammalian PREs 
contain YY1 motifs (Woo, Kharchenko et al. ; Sing, Pannell et al. 2009). The 44 kb hZfpm2 
BAC contains 11 instances of the consensus YY1 motif. However, none of these reside within 
the CpG island (Figure 2.4A-B) (see Methods). We also examined YY1 binding directly in ES 
cells and NS cells using ChIP-Seq. Consistent with prior reports, YY1 binding is evident at the 
5’ ends of many highly expressed genes, including those encoding ribosomal proteins, and is also 
seen at the imprinted Peg3 locus (Figure 2.4C) (Kim, Kang et al. 2009). However, no YY1 
enrichment is evident at the Zfpm2 locus.    65 
 
 
Figure 2.4. YY1 is not Directly Involved in PRC2 Recruitment in Mammalian ES Cells 
(A) The GC-richness and locations of YY1 motifs for the Zfpm2 locus are shown. (B) The 1.7 
kb CpG island contains 4 conserved motifs (see Methods). (C) ChIP-Seq was used to profile the 
mammalian Pho homolog YY1 in mouse ES cells. Genome browser views show ChIP-Seq 
enrichment signals for K4me3, K27me3, Ezh2 and YY1 for YY1 target loci. (D) Venn diagram 
shows overlap of K4me3, Ezh2, Ring1b, and YY1 at promoters in mES cells.    
     66 
Moreover, at a global level, YY1 shows almost no overlap with PRC2 or PRC1, but instead co-
localizes with genomic sites marked exclusively by K4me3 (Figure 2.4D). Thus, although YY1 
may contribute to Polycomb-mediated repression through distal interactions or in trans, it does 
not appear to be directly involved in PRC2 recruitment in ES cells. 
 
DISCUSSION 
 
  Several lines of evidence suggest that the initial landscape of Polycomb complex binding 
is critical for proper patterning of gene expression in metazoan development (Ringrose and Paro 
2007; Schwartz and Pirrotta 2007; Schuettengruber, Ganapathi et al. 2009). Failure of these 
factors to engage their target loci in embryogenesis has been linked to a loss of epigenetic 
repression at later stages. Accordingly, the determinants that localize Polycomb complexes at the 
pluripotent stage are almost certainly essential to the global functions of these repressors through 
development.  
  We find that DNA sequence is sufficient for proper localization of Polycomb repressive 
complexes in ES cells, and specifically identify a CpG island within the Zfpm2 locus as being 
critical for recruitment. We provide evidence that YY1 is not directly involved in PRC2 
recruitment in ES cells.   
  Several possible mechanistic models could explain the causality of GC-rich DNA 
elements in PRC2 recruitment. First, we note that CpG islands have been shown to destabilize 
nucleosomes in mammalian cells (Ramirez-Carrozzi, Braas et al. 2009). At transcriptionally 
inactive loci, this property could increase their accessibility to PRC2-associated proteins with 
DNA affinity but low sequence specificity, such as Jarid2 or AEBP2 (Li, Margueron et al. ;   67 
Pasini, Cloos et al. ; Kim, Kang et al. 2009; Peng, Valouev et al. 2009; Shen, Kim et al. 2009). 
Although this association would be abrogated by transcriptional activity at most CpG islands, 
those lacking activation signals would remain permissive to PRC2 association. In support of this 
model, PRC2 targets in ES cells are also enriched for H2A.Z and H3.3, histone variants linked to 
nucleosome exchange dynamics (Goldberg, Banaszynski et al. ; Creyghton, Markoulaki et al. 
2008). Alternatively or in addition, targeting could be supported by DNA binding proteins with 
affinity for low complexity GC-rich motifs or CpG dinucleotides, such as CXXC domain 
proteins (Tate, Lee et al. 2009). Localization may also be promoted or stabilized by long and 
short non-coding RNAs (Kanhere, Viiri et al. ; Tsai, Manor et al. ; Rinn, Kertesz et al. 2007; 
Zhao, Sun et al. 2008) as well as by the demonstrated affinity of PRC2 for its product, 
H3K27me3 (Hansen, Bracken et al. 2008; Margueron, Justin et al. 2009). Notably, PRC2 
recruitment in ES cells appears distinct from that in Drosophila, as we do not find evidence for 
involvement of PRE-like sequence motifs or mammalian homologues such as YY1.  
  It should be emphasized that PRC2 localization does not necessarily equate with 
epigenetic repression. Indeed virtually all PRC2 bound sites in ES cells, and all CpG islands 
tested here, are also enriched for K4me3, and presumably poised for activation upon 
differentiation. Epigenetic repression during differentiation may require PRC1 and thus depend 
on additional binding determinants. YY1 remains an intriguing candidate in this regard, given 
prior evidence for physical and genetic interactions with PRC1 (Garcia, Marcos-Gutierrez et al. 
1999; Lorente, Perez et al. 2006). YY1 consensus motifs are present in the Polycomb-dependent 
silencing elements recently identified in the MafB and HoxD loci. Interestingly, the HoxD 
element combines a CpG island with a cluster of conserved YY1 motifs. Mutation of the motifs 
abrogated PRC1 binding but left PRC2 binding intact. Still, the fact that only a small fraction of   68 
documented PRC2 and PRC1 sites have YY1 motifs or binding suggests that this transcription 
factor may act indirectly and/or explain only a subset of cases. Nonetheless, it is likely that a 
fully functional epigenetic silencer would require a combination of features, including a GC-rich 
PRC2 element as well as appropriate elements to recruit PRC1. Further study is needed to 
expand the rules for PRC2 binding to include a global definition of PRC1 determinants and 
ultimately, to understand how the initial landscape facilitates the maintenance of gene expression 
programs in the developing organism. 
  Finally, we note that here, we used Ezh2 and Ring1B as proxies for the entire PRC2 and 
PRC1 complexes, respectively. While EZH2 and Ring1B are catalytic components and likely to 
be a member of every PRC2 or PRC1 complex, other members may only bind to a subset of 
targets. Attempts to characterize the binding of additional PRC2 and PRC1 components using 
ChIP-seq often failed due to the lack of high-quality antibodies and the difficulty of crosslinking 
loosely bound proteins. Thus, to fully understand the intricacies of PRC2 and PRC1 binding, 
new technology is needed to more reliably characterize chromatin proteins. We discuss one such 
technology in the next Chapter.   
 
METHODS 
 
BAC Construct Design 
 
  BAC constructs CTD331719L (‘Zfpm2 44’) and CTD-3219L19 (‘Gene Desert’) were 
obtained from Open Biosystems. Recombineering was done using the RedET system (Open 
Biosystems) in DH10B cells. Homology arms 200-500 bp in length were PCR amplified and   69 
cloned into a PGK; Neomycin cassette (Gene Bridges). This cassette was used to recombineer all 
BACs to enable selection in mammalian cells. The 22 kb hZfpm2 BAC was created by 
restricting the hZfpm2 BAC at two sites using ClaI, and re-ligating the BAC lacking the 
intervening sequence. The CpG island was excised from the 22 kb hZfpm2 BAC by 
amplification of flanking homology arms, and cloned into a construct containing an adjacent 
ampicillin cassette (Frt-amp-Frt; Gene Bridges). After recombination, the ampicillin cassette was 
removed using Flp-recombinase and selection for clones that lost ampicillin resistance (Flp-706; 
Gene Bridges).  PCR across the region confirmed excision of the CpG island. For the Gene 
Desert BAC, the Zfpm2 CpG island was amplified with primers containing XhoI sites and 
cloned into the Frt-amp-Frt vector that contains homology arms from the Gene Desert region. 
The final constructs were confirmed by sequencing across recombination junctions. 
 
Transgenic ES Cell and ChIP Experiments 
 
  ES cells (V6.5) were maintained in ES cell medium (DMEM; Dulbecco’s modified 
Eagle’s medium) supplemented with 15% fetal calf serum (Hyclone), 0.1 mM ß-mercaptoethanol 
(Sigma), 2 mM Glutamax, 0.1 mM non-essential amino acid (NEAA; Gibco) and 1000U/ml 
recombinant leukemia inhibitory factor (ESGRO; Chemicon). Roughly 50 µg of linearized BAC 
was nucleofected using the mouse ES cell nucleofector kit (Lonza) into 10
6 mouse ES cells, and 
selected 7-10 days with 150 µg/ml Geneticin (Invitrogen) on Neomycin resistant MEFs 
(Millipore). Individual resistant colonies were picked, expanded and tested for integration of the 
full length BAC by PCR. 
  For each construct, between one and three ES cell clones were expanded and subjected to   70 
ChIP using antibody against K4me3 (Abcam ab8580 or Upstate/Millipore 07-473), K27me3 
(Upstate/Millipore 07-449), Ezh2 (Active Motif 39103 or 39639), or Ring1B (MBL International 
d139-3) as described previously (Bernstein, Mikkelsen et al. 2006; Mikkelsen, Ku et al. 2007; 
Ku, Koche et al. 2008). ChIP DNA was quantified by Quant-iT Picogreen dsDNA Assay Kit 
(Invitrogen). ChIP enrichments were assessed by quantitative PCR analysis on an ABI 7500 with 
0.25 ng ChIP DNA and an equal mass of un-enriched input DNA. Enrichments were calculated 
from 2 or 3 biologically independent ChIP experiments. For K27me3, and Ezh2 enrichment, 
background was subtracted by normalizing over a negative genomic control. Error bars represent 
standard error of the mean (SEM). We confirmed that the human specific primers do not non-
specifically amplify mouse genomic DNA. 
 
Genomic and Computational Analysis 
 
  Genomewide maps of YY1 binding sites were determined by ChIP-Seq as described 
previously (Mikkelsen, Ku et al. 2007). Briefly, ChIP was carried out on 6x10
7 cells using 
antibody against YY1 (Santa Cruz Biotechnology sc-1703). ChIP DNA was used to prepare 
libraries which were sequenced on the Illumina Genome Analyzer. Density profiles were 
generated as described (Mikkelsen, Ku et al. 2007). Promoters (RefSeq; http://genome.ucsc.edu) 
were classified as positive for YY1, H3K4me3 or H3K27me3 if the read density was 
significantly enriched (p < 10
-3) over a background distribution based on randomized reads 
generated separately for each dataset to account for the varying degrees of sequencing depth. 
ChIP-Seq data for YY1 are deposited to the NCBI GEO database under the following accession 
number GSE25197 (http://www.ncbi.nlm.nih.gov/projects/geo/query/acc.cgi?acc=GSE25197).   71 
Sites of Ezh2 enrichment (p < 10
-3) were calculated genomewide using sliding 1 kb windows, 
and enriched windows within 1 kb were merged. 
  YY1 motifs were identified using the MAST algorithm (Bailey and Gribskov 1998) 
where a match to the consensus motif was defined at significance level 5 x 10
-5. Motifs shown in 
Figure 2.4 are from UCSCs TFBS conserved track. 
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ABSTRACT 
 
Next-generation sequencing has greatly advanced our ability to study chromatin on a 
genomewide scale, and has been applied to globally characterize DNA methylation, histone 
modifications, and transcription factor binding, among other properties. However, we currently 
lack an ideal comprehensive assay for identifying the genomewide binding patterns of chromatin 
proteins, as current methods are hindered by difficulty crosslinking loosely or transiently bound 
proteins and poor antibodies. Here, we adapt a method for mapping chromatin regulators that 
uses a fusion enzyme and that does not rely on crosslinking and antibodies, and show that it can 
be used to globally map chromatin proteins in both human K562 and 293T cells. 
 
INTRODUCTION 
 
The human genome, at the most basic level, is a sequence of over three billion base pairs 
that is identical in virtually every cell of the human body. As the adult human body consists of 
over 100 trillion cells that correspond to at least 200 histologically unique cell types, the 
establishment and maintenance of these discrete and stable states is key to cell identity and 
differentiation. Cell state may be established and maintained by numerous factors, including 
DNA methylation, transcription factors, and chromatin proteins (Zhou, Goren et al. 2011). In 
recent years, technological advancements in next-generation sequencing have enabled many of 
these factors to be mapped genomewide.  
While existing methods for genomewide mapping of factor binding work well for histone 
modifications and transcription factors, they have limited applicability to chromatin proteins.  	 ﾠ 81 
 
 
 
Figure 3.1. Comparison Between ChIP-seq and DamID-seq Technologies 
Schematic overview of steps for ChIP-seq and DamID-seq. (A) In ChIP-seq, a bound protein 
(dark blue) is crosslinked to DNA by formaldehyde. The crosslinked sample is sonicated until 
the DNA is 100-500bp in length. Then, the protein, along with the chromatin crosslinked to it, is 
pulled-down with an antibody that has been incubated with Protein A or G beads. The crosslinks 
are reversed by heat, and the DNA is purified. The DNA is sequenced, aligned to the genome, 
and viewed with the Integrative Genomics Viewer, which displays a histogram corresponding to 
the number of sequence reads at each genomic location. The shaded boxes indicate steps that 
often do not work well for chromatin proteins. (B) In DamID-seq, a bound protein (dark blue) is 
fused to DNA adenine methyltransferase (light blue). The Dam methylates adenines at nearby 
GATC sites (red). The methylated DNA is isolated, and the methylated regions are amplified by 
PCR. Note that after PCR, the DNA is no longer methylated, but in this schematic, we included 
the methylation marks for simplicity. The DNA fragments are then sonicated to 100-500bp in 
length, and the originally methylated ends are pulled-down with beads. The DNA is sequenced, 
aligned to the genome, and viewed with the Integrative Genomics Viewer, which displays a 
histogram corresponding to the number of sequence reads at each GATC site. 
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Figure 3.1 (Continued).   	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Specifically, chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-
seq) is limited by poor crosslinking of loosely or transiently bound proteins, the lack of high-
quality antibodies, poor solubility of compact chromatin, and the high sequencing depth 
necessary for broadly bound proteins (Figure 3.1). Although recent studies have begun to 
overcome these limitations through new chromatin immunoprecipitation procedures and 
antibody screening (Ram, Goren et al. 2011; Rhee and Pugh 2011), the vast majority of 
chromatin regulators remain uncharted. A complementary method that does not rely on 
antibodies and formaldehyde crosslinking, and that is based on a reduced representation of the 
genome, is needed to thoroughly address the binding of chromatin proteins. 
  In 2000, Bas van Steensel and Steven Henikoff presented a method called DamID for 
identifying binding sites of chromatin proteins by using a tethered E.coli DNA adenine 
methyltransferase (Dam) (van Steensel and Henikoff 2000). This method does not require 
crosslinking or antibodies, and samples the genome at GATC sites. They and others then used 
microarrays to create genomewide maps from these DamID libraries for various Drosophila 
proteins (van Steensel, Delrow et al. 2001; Greil, van der Kraan et al. 2003; Orian, van Steensel 
et al. 2003; Sun, Chen et al. 2003; van Steensel, Delrow et al. 2003; Bianchi-Frias, Orian et al. 
2004; de Wit, Greil et al. 2005). In 2006, the van Steensel lab reported the application of 
DamID-microarray to mammalian cells (Vogel, Peric-Hupkes et al. 2007). Using this 
technology, they were able to map both CBX1 and nuclear lamina in mammalian cells (Vogel, 
Guelen et al. 2006; Guelen, Pagie et al. 2008). 
Here, we adapted DamID for use with high-throughput sequencing, which we call 
DamID-seq (Figure 3.1). We used DamID-seq to profile the genomewide binding of chromatin 
proteins in both human K562 and 293T cells. We anticipate that this technology can complement 	 ﾠ 84 
existing methods to generate a complete picture of chromatin in various cell types. 
 
RESULTS 
 
DamID is Adapted for High-Throughput Sequencing 
 
To develop a new technology for genomewide mapping of mammalian chromatin 
proteins that addresses the limitations of ChIP-seq, we adapted DamID for high-throughput 
sequencing. DamID is based on fusing a protein of interest with E. coli DNA adenine 
methyltransferase (Dam), which methylates adenines at GATC sites (Vogel, Peric-Hupkes et al. 
2007). This fusion protein is inserted into mammalian cells by lentiviral infection. Inside the cell, 
the fusion protein binds DNA and marks nearby GATC sequences with adenine methylation 
(Figure 3.1). By isolating the genomic DNA (gDNA) and amplifying the methylated regions, one 
can map the binding sites for the protein of interest. 
To date, all published mammalian DamID libraries have been queried by microarray. For 
instance, DamID followed by microarray has been used to map CBX1 in MCF7 human breast 
carcinoma cell lines (Vogel, Guelen et al. 2006), laminB1 in human fibroblasts (Guelen, Pagie et 
al. 2008), and 53 chromatin proteins in Drosophila (Filion, van Bemmel et al. 2010). 
There are several advantages to sequencing DamID libraries over using microarrays: 
sequencing offers quantitative digital data and no hybridization bias. To capitalize on the benefits 
of sequencing, we designed a method for amplifying methylated fragments that enables capture 
of each individual methylated GATC site. Sequencing such a library reveals counts for 
methylation of every GATC site, from which the binding pattern of the protein can be inferred. 	 ﾠ 85 
 
 
 
 
 
 
 
 
Figure 3.2. DamID-seq Technology 
Schematic of steps for adapting DamID for high-throughput sequencing. Methylated DNA is 
digested with DpnI, ligated with adaptors, amplified by PCR with a biotinylated primer (blue 
circle), fragmented with Covaris, pulled-down by streptavidin beads (yellow circle), digested 
with DpnII, and prepared for high-throughput sequencing. 
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Specifically, we amplified methylated fragments by first digesting gDNA with DpnI, 
which cuts methylated GATC sites, and ligating adaptors at these cut ends (Figure 3.2). These 
fragments are then amplified with a biotinylated primer, yielding fragments ranging from 0.4-
3kb in size. To shorten these fragments to a size amenable to sequencing, they are sonicated 
using Covaris until 100-500bp in size.  
Since we only want to sequence methylated GATC sites, which are located at the 
biotinylated ends of these fragments, we pulled down such fragments with streptavidin beads. 
The DNA was cut off from the beads with DpnII, which digests GATC sites regardless of 
methylation status. The resulting sequencing library consists of GATC sites followed by the 
flanking DNA sequence that can be used to map these sites to the human genome. 
 
Validation of DamID-seq with Replicates 
 
  We used DamID-seq to map the genomewide binding of a chromatin protein (CBX8) and 
a nuclear lamina protein (LMNB1) in K562 cells (Figure 3.3A). We generated over 22 million 
reads for CBX8, and over 20 million reads for LMNB1. We filtered for reads that start with 
GATC, which resulted in over 9 million and over 8 million reads for CBX8 and LMNB1, 
respectively. If our pull-down was 100% efficient, we would expect 50% of the reads to start 
with GATCs, so our pull-downs appear to be 80-90% efficient. Our GATC-starting read 
numbers corresponds to 1.3x and 1.1x coverage of GATC sites in the genome. While this 
coverage is sufficient because our enrichment method isolates but a small fraction of such sites, 
we note that additional sequencing reads, and thereby greater coverage, can improve the 
sensitivity of our method. 	 ﾠ 88 
 
Figure 3.3. Validation of DamID-seq with Replicates 
(A) DamID-seq tracks of two replicates each of CBX8 (blue), LMNB1 (red), and Dam only 
(black) in K562 cells. 
(B) Scatter plots comparing 2 kb bins of reads between the two replicates of CBX8, the two 
replicates of LMNB1, and the two replicates of Dam only. The red number in the upper left 
corner is the correlation. 
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We performed two biological replicates each for CBX8 and LMNB1 (Figure 3.3A). The 
resulting maps clearly show consistent binding peaks for both proteins. CBX8 peaks appear 
punctate, as would be expected by its role as a member of the Polycomb repressive complex 1 
(Beisel and Paro 2011). LMNB1, on the other hand, binds to broad Megabase domains, which is 
consistent with previous reports (Guelen, Pagie et al. 2008). 
  We then quantitatively compared the two biological replicates with each other by 
comparing read numbers found in 2kb windows across the genome (Figure 3.3B). We found that 
the CBX8 replicates had a correlation coefficient of 0.8, and that the LMNB1 replicates had a 
correlation coefficient of 0.64. These are reasonably high values for distinct biological samples, 
and validates that DamID-seq is a robust method. CBX8 replicates likely have a higher 
correlation coefficient than LMNB1 replicates because it has more total sequencing reads, and 
therefore greater coverage. Furthermore, since CBX8 peaks are narrower than that of LMNB1, 
its effective coverage is even greater. 
  Finally, we conducted a control to test for potential false positives resulting from the 
background binding of the Dam protein or PCR duplicates. We mapped the genomewide binding 
of the Dam protein by itself in two biological replicates (Figure 3.3A). Both replicates show that 
the Dam protein binds at a basal level across the region, with a few modest peaks that correspond 
to either regions that Dam preferentially binds or PCR duplicates. However, these patterns do not 
account for the strong binding peaks found in the CBX8 or LMNB1 maps, indicating that those 
peaks are primarily due to the binding of the protein of interest. 
We also quantitatively compared the two Dam replicates with each other and found a 
correlation coefficient of 0.30 (Figure 3.3B). This low correlation is expected for a control 
protein that binds at a low level across the entire genome, and validates that the Dam protein by 	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itself does not have notable binding preferences.  
 
Limited Bias in DamID-seq  
 
  We sought to identify and quantify the sources of bias in DamID-seq data. We first 
examined bias resulting from the GATC distribution, since reads must map to GATC sites. For 
2kb bins across one representative chromosome, we compared the number of GATCs with the 
number of DamID-seq reads by plotting a log-scale density scatter plot (Figure 3.4A). We 
examined both reads from the Dam only map, and reads from the CBX8 map. We found that 
there were strong correlations of 0.70 and 0.61, respectively, between the number of GATC sites 
and the number of reads, which is expected given our technology. 
  Next, we asked whether we could counter this GATC bias by normalizing the reads by 
the number of GATC sites per 2kb bin and again plotting a log-scale density scatter plot (Figure 
3.4B). Indeed, there is a low correlation between the number of GATC sites and the normalized 
number of reads. The correlation coefficient for Dam only data is 0.29, and for CBX8 data, 0.23. 
The limited remaining GATC bias may result from the fact that two methylated GATC sites are 
required to amplify a given region. Since our PCR fragments appear to range from 400bp - 3kb, 
we may miss potential positive regions if there are fewer than two GATC sites within 3kb. 
  We then examined bias resulting from the G+C content of the DNA sequence, which can 
affect PCR amplification and sequencing. For 2kb bins across one representative chromosome, 
we compared the G+C percentage with the log of the number of DamID-seq reads by plotting a 
density scatter plot (Figure 3.4C-D).  
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Figure 3.4. Limited Bias in DamID-seq  
(A) For 2 kb bins across chromosome 19, density scatter plot comparing the natural log of 
number of GATCs with the natural log of Dam reads (left) or CBX8 reads (right). A low density 
of points is colored blue, and a high density of points is colored red. The correlation coefficient 
is indicated in red at the upper left-hand corner. (B) For 2 kb bins across chromosome 19, density 
scatter plot comparing the natural log of number of GATCs with the natural log of Dam reads 
normalized by the number of GATCs (left) or CBX8 reads normalized by the number of GATCs 
(right). A low density of points is colored blue, and a high density of points is colored red. The 
correlation coefficient is indicated in red at the upper right-hand corner. (C) For 2 kb bins across 
chromosome 19, density scatter plot comparing the G+C percentage with the natural log of Dam 
reads (left) or CBX8 reads (right), for G+C percentages above the median. A low density of 
points is colored blue, and a high density of points is colored red. The correlation coefficient is 
indicated in red at the upper right-hand corner. (D) For 2 kb bins across chromosome 19, density 
scatter plot comparing the G+C percentage with the natural log of Dam reads (left) or CBX8 
reads (right), for G+C percentages below the median. A low density of points is colored blue, 
and a high density of points is colored red. The correlation coefficient is indicated in red at the 
upper left-hand corner. 
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We found that the G+C bias was nonlinear, so we split the plots into bins with G+C content 
above the median (Figure 3.4C) and bins with G+C content below the median (Figure 3.4D). For 
high G+C bins, there is a negative correlation between G+C percentage and number of reads: 
namely, -0.44 for Dam only data and -0.52 for CBX8 data. In contrast, for low G+C bins, there is 
a modest positive correlation between G+C percentage and number of reads: namely, 0.35 for 
Dam only data and 0.36 for CBX8 data. This is comparable to the G+C bias found in ChIP-seq 
data (Goren, Ozsolak et al. 2010). Thus, DamID-seq appears to have a limited GATC bias and 
G+C bias that is comparable to existing technology. 
 
DamID-seq in Multiple Human Cell Types 
 
  We have used DamID-seq to map chromatin proteins in two human cell lines: K562 cells, 
which are suspension cells derived from myelogenous leukemia (Figure 3.3), and 293T cells, 
which are adherent cells derived from embryonic kidney (Figure 3.5). To apply DamID-seq to 
different cell types, we optimized the lentiviral infection protocol for each case. We found that 
the remainder of the protocol works well regardless of the cell type. Thus, we predict that 
DamID-seq can be used to map as many human cell types as can be infected by lentivirus. 
  For the map of chromatin protein CBX1 in 293T cells, we conducted one additional 
control to test for potential false negatives resulting from the PCR step. Specifically, the PCR 
step amplifies regions between methylated GATC sites, even if there is an unmethylated GATC 
site in between (Figure 3.2). We reasoned that the chance of this occurring is modest because the 
Dam protein has a reach of 1kb from its binding site, while the PCR products are only up to 3kb 
in length (van Steensel and Henikoff 2000).  	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Figure 3.5. DamID-seq in 293T Cells 
DamID-seq tracks of CBX1 and Dam only in 293T cells. The “-DpnII” maps were constructed 
according to the general protocol, as outlined in Figure 3.2. The “+DpnII” maps were 
constructed with an additional DpnII digestion after the adaptor ligation, and before the overhang 
fill-in and PCR amplification. 
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We experimentally verified this by introducing a DpnII digestion after the adaptor ligation, and 
before the overhang fill-in and PCR amplification. We found that with or without this additional 
DpnII digestion, the resulting map reveals similar broad binding peaks (Figure 3.5). Thus, we 
concluded that there were no major false positives resulting from the PCR step. 
 
DISCUSSION 
 
  Here, we adapted DamID for high-throughput sequencing to create genomewide maps of 
chromatin proteins. This method circumvents the need for crosslinking and antibodies, and is 
particularly suited for broadly, loosely, and transiently bound proteins. We envision that DamID-
seq will complement ChIP-seq, which is better suited for mapping histone modifications, 
transcription factors and other proteins that intimately interact with the DNA. This approach 
should help to build a complete picture of chromatin in mammalian cells.  
We note that for proteins that can be readily mapped by both ChIP-seq and DamID-seq, 
ChIP-seq may be the better choice, as it profiles the endogenous protein over 10 minutes at a 
25bp resolution. DamID-seq, on the other hand, profiles a lowly expressed exogenous fusion 
protein over 3 days at a 1kb resolution. However, for proteins that cannot be mapped by ChIP-
seq, such as the nuclear lamina and other broad proteins in regions of compact chromatin or 
without high-quality antibodies, DamID-seq may be the only option for obtaining a genomewide 
map of binding. 
We further note that DamID-seq is uniquely capable of mapping mutant proteins, which 
will be essential for studying disease states. During the cloning step of the DamID-seq protocol, 
the sequence of the protein of interest can be mutated, so that when it is expressed in the cell, a 	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mutant protein will be fused to the Dam protein. We can then generate a map of the mutant 
protein’s binding, and compare it to a map of the wild-type protein’s binding to identify aberrant 
patterns. This could further our understanding of the many diseases that involve mutant DNA-
binding proteins. 
  To use DamID-seq to globally characterize mammalian chromatin, we need to develop a 
peak caller to interpret binding regions from the maps, and to map additional chromatin proteins 
to begin to illuminate genomewide patterns. We will address these issues in the next Chapter. 
 
METHODS 
 
Plasmid Construction 
 
We obtained plasmids pLgw V5-EcoDam (Dam only negative control), pLgw EcoDam-
V5-RFC1 (N-terminus Dam vector), pLgw RFC1-V5-EcoDam (C-terminus Dam vector), and 
pLgw CBX1-V5-EcoDam (CBX1-Dam positive control) from the Bas van Steensel laboratory. 
We obtained ORFs in plasmid pDONR221 (or pDONR201) for CBX8 (cloneID 
HsCD00079972) and LMNB1 (clone ID HsCD00043675) from the PlasmID collection at the 
Dana-Farber/Harvard Cancer Center DNA Resource Core. 
  We used Invitrogen Gateway® Cloning technology to clone these ORFs into either pLgw 
EcoDam-V5-RFC1 (N-terminus Dam vector) or pLgw RFC1-V5-EcoDam (C-terminus Dam 
vector), depending on whether the available ORF had a stop codon. Namely, LMNB1 was 
cloned with an N-terminus Dam, and CBX8 was cloned with a C-terminus Dam. 
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Cell Culture 
 
293T cells were grown according to standard protocols in Gibco KO DMEM media 
supplemented with 10% fetal bovine serum (FBS, Atlas Biologicals, F-0500-A), 1% 
Penicillin/Streptomycin (Invitrogen, 15140122), and 1% Glutamax. K562 erythrocytic leukemia 
cells (ATCC CCL-243) were grown according to standard protocols in RPMI 1640 media 
(Invitrogen, 22400105) supplemented with 10% fetal bovine serum (FBS, Atlas Biologicals, F-
0500-A) and 1% Penicillin/Streptomycin (Invitrogen, 15140122). 
 
Lentiviral Production 
   
293T cells were grown in 15cm dishes until 60-80% confluence. 1140uL of DMEM was 
combined with 60uL of Fugene. After 5 min, the following three plasmids were added: Gag, pol 
and rev plasmid (6ug), VSV envelope plasmid (3ug), and specific cloned Dam-protein plasmid 
or GFP (9ug). This mixture was incubated at room temperature for 5 min, then added dropwise 
to the 293T cells. After 8-12 hours, the media was replaced with 12mL fresh medium. After 72 
hours, the virus was collected filtered through 0.45 uM. For K562 infections, the virus was 
ultracentrifuged at 28000 rpm for 2 hours in an SW41Ti rotor at 4°C. The virus was resuspended 
in 100uL PBS, and left at 4°C overnight. 
 
293T Lentiviral Infection 
 
293T cells were plated in two wells of a 6-well plate and grown until 70% confluency for 	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each experiment. For each well, 1.5uL Polybrene (10mg/mL) was added and incubated for 
30min, before adding 0.75mL of unconcentrated virus and 0.75mL of media. The cells were then 
returned to 37°C overnight. 
The next day, 2mL fresh media was added per well to dilute out the virus. After 48 hours 
later, the cells were harvested and the gDNA was isolated using the Qiagen DNA Micro Kit, 
“Isolation of gDNA from Small Volumes of Blood” protocol. The DNA was eluted in 200uL 
buffer AE, and quantified by Nanodrop. 
 
K562 Lentiviral Infection 
   
K562 cells were counted with a hemacytometer and 1.5 million cells were allocated per 
each infection. Each aliquot of cells was spun down and resuspended in 3mL fresh media, and 
plated in one well of a 6-well plate. 2uL Polybrene (10mg/mL) and 30uL of concentrated virus 
were added. The cells were spin-infected at 2500 rpm, for 90 min, at room temperature. The cells 
were then returned to 37°C overnight. 
  The following day, the infected cells were spun down and resuspended in 3mL fresh 
media. After 48 hours later, the cells were harvested and the gDNA was isolated using the 
Qiagen DNA Micro Kit, “Isolation of gDNA from Small Volumes of Blood” protocol. The DNA 
was eluted in 200uL buffer AE, and quantified by Nanodrop. 
 
DamID Library Preparation and Sequencing 
   
The gDNA was ethanol precipitated, and dissolved in TE pH7.5 to a concentration of 1 	 ﾠ 99 
ug/uL. 2.5uL of gDNA was digested with 0.5uL of DpnI (NEB, 20 U/uL) at 37°C overnight in 
PCR tubes. DpnI was inactivated by heating to 80°C for 20 min. The DpnI-digested gDNA was 
ligated with the adaptor AdR, which is made by mixing and slowly annealing AdR-top (5’ 
CTAATACGACTCACTATAGGGCAGCGTGGTCGCGGCCGAGGA 3’) and AdR-bottom (5’ 
TCCTCGGCCG 3’). This ligation was completed using 1uL T4 Ligase (Roche, 5U/uL) for 2 
hours at 16°C. The T4 ligase was inactivated by heating to 65°C for 10 min. The resulting 20uL 
volume reaction was diluted to 50uL with ddH2O. 
  To amplify the regions flanked by adaptors, the following PCR was setup: 10uL DNA, 
5uL 10x cDNA PCR reaction buffer (Clontech), 0.625uL primer bio-Adr-PCR (5’ bio-
GGTCGCGGCCGAGGATC 3’, 100uM), 1uL dNTPs (10mM), 1uL PCR advantage enzyme 
mix (Clontech, 50X), 32.375uL ddH2O. The PCR reaction program was as follows: 1 cycle of 
68°C (10min), 94°C (1min), 65°C (5min), 68°C (15min); 3 cycles of 94°C (1min), 65°C (1min), 
68°C (10min); 17 cycles of 94°C (1min), 65°C (1min), 68°C (2min). 5uL of the PCR products 
were ran on a gel to verify successful digestion and amplification. 
  The PCR products were cleaned with the Qiagen MinElute PCR Purification kit, and 
eluted in 20uL ddH2O. Following quantification by Nanodrop, 3ug of each sample was diluted 
in 100uL ddH2O. These samples were sonicated with Covaris using the following settings: 10% 
duty cycle, 5 intensity, 200 cycles per burst, for 4.5 min total. 10uL of the Covaris-sonicated 
samples were ran on a gel to verify sonication to 100-500bp. 
  To pull down the biotinylated ends of the PCR products, we used Invitrogen Dynabeads® 
MyOne Streptavidin T1 beads. 50uL of these beads were washed three times with 50uL of 1X 
Binding and Washing (B&W) buffer (5mM Tris-HCl pH 7.5, 0.5mM EDTA, 1M NaCl). The 
washed beads were resuspended in 75uL of Covaris-sonicated DNA, 100uL of 2X B&W buffer, 	 ﾠ 100 
and 25uL H2O. This mixture was incubated at 4°C for 15min on a rotator. Following a quick 
spin and decanting the supernatant, the beads were washed three times with 200uL of 1X B&W 
buffer. 
  The bound DNA was removed off the beads by digestion with DpnII at 37°C for 1 hour. 
The supernatant was collected and cleaned using the Qiagen MinElute Reaction Cleanup kit. The 
resulting DNA was eluted in 20uL H2O and quantified with Qubit. qPCR analysis was 
performed to validate the DamID DNA before submission for sequencing. 
  Libraries of DamID samples were prepared according to the Illumina Genomic DNA 
protocol, as described previously (Mikkelsen et al., 2007). The DamID-seq libraries were 
sequenced on Illumina GAII sequencers according to standard Illumina protocols. 
 
DamID-seq Data Analysis 
 
Sequence reads were aligned to the human genome reference (hg19). We filtered out low-
quality reads, and filtered in reads that map to GATC sites. The number of reads was counted at 
each GATC site. The reads were viewed using the Integrative Genomics Viewer 
(http://www.broadinstitute.org/igv/). 
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ABSTRACT 
 
Chromatin is a multi-layered structure composed of DNA, histones, and associated 
proteins. While histone modifications and transcription factors are readily mapped by ChIP-seq, 
DamID-seq can map chromatin proteins, which are often broadly, loosely and transiently bound. 
Here, we developed a DamID-seq peak caller, which identifies binding sites for chromatin 
proteins using a ratio between the protein map and a Dam only control map. We used DamID-
seq and the peak caller to map the binding of 12 chromodomain-containing and related proteins 
in human K562 cells. We found that our proteins cluster into two modules: 1) Polycomb-related 
and 2) heterochromatin-related. Polycomb proteins bind developmental genes, while 
heterochromatin proteins CBX1, 3, and 5 bind broad olfactory receptor (OR) and zinc finger 
(ZNF) domains. Surprisingly, unlike other Polycomb proteins, CBX2 uniquely binds to genes 
involved with modifying proteins. Our findings advance the model that the genome is 
compartmentalized into domains, and identify the distinct protein components that associate 
respectively with Polycomb and heterochromatin domains in human cells. 
 
INTRODUCTION 
 
  The mammalian genome is bound by hundreds of chromatin proteins that serve the dual 
purpose of structurally compacting the genome within the nucleus and functionally regulating its 
underlying DNA sequence. Many of these proteins work in combination and affect broad 
genomic regions, advancing a model in which the genome may be compartmentalized into 
higher-order domains. 	 ﾠ 108 
  Recent work lends support to a domain organization of the genome. Megabase (Mb) 
domains of H3K9me2 and lamina association sequester silenced heterochromatic regions 
(Guelen, Pagie et al. 2008; Wen, Wu et al. 2009). H3K27me3 blocks and Polycomb bodies may 
repress large sets of genes upon differentiation (Sexton, Schober et al. 2007; Pauler, Sloane et al. 
2009). Furthermore, several large-scale profiling studies of chromatin proteins consistently 
reveal a limited number of domains: five chromatin “colors” in fly (Filion, van Bemmel et al. 
2010), and six “modules” in human (Ram, Goren et al. 2011).  
Despite the suggestion of the above studies that chromatin proteins can be divided into a 
relatively limited number of domains, biochemical and imaging studies on individual chromatin 
proteins have long emphasized their unique binding patterns. An exemplar is the eight human 
CBX proteins, which all contain one chromodomain that recognizes methylated histone lysines 
(Yap and Zhou 2011). Five of these proteins (CBX2, 4, 6, 7, 8) are homologous to Drosophila Pc 
(dPc), and the other three (CBX1, 3, 5) are homologous to Drosophila HP1 (dHP1). Despite their 
similarities in structure, each CBX protein has a distinct in vitro peptide binding specificity 
(Kaustov, Ouyang et al. 2011), subnuclear distribution (Vincenz and Kerppola 2008), and 
binding partners (Lomberk, Wallrath et al. 2006; Rosnoblet, Vandamme et al. 2011; Vandamme, 
Volkel et al. 2011). However, a high-resolution, genomewide comparison of their in vivo binding 
patterns is yet to be elucidated. 
Existing methods for mapping in vivo binding genomewide have limited applicability to 
chromatin proteins. In the previous Chapter, we adapted DamID for high-throughput sequencing 
to create DamID-seq, which relies on a fusion enzyme, rather than antibodies and formaldehyde 
crosslinking, and can address the binding of chromatin proteins, which are often broadly, 
loosely, or transiently bound. 	 ﾠ 109 
  Here, we used DamID-seq to map the genomewide binding of 12 chromatin proteins in 
human K562 cells. Specifically, we chose to leverage the power of DamID-seq by mapping 
proteins that are thought to be broadly and loosely bound to chromatin: CBX proteins, Polycomb 
repressive complex 1 (PRC1) and 2 (PRC2) components, and nuclear lamina. We also developed 
a new peak caller that enabled us to generate novel insights about the global binding patterns of 
these proteins in mammals. 
Globally, we found that our panel of chromatin proteins clusters into two major modules: 
1) Polycomb-related, and 2) heterochromatin-related. While Polycomb proteins bind to 
developmental genes, heterochromatin proteins CBX1, 3, and 5 bind to broad olfactory receptor 
(OR) and zinc finger (ZNF) protein clusters. CBX2 surprisingly exhibits unique binding patterns, 
different from either protein group. Our findings suggest that Polycomb and heterochromatin 
domains exhibit distinct properties, and further advance a domain model of the genome. 
 
RESULTS 
 
A New Peak Caller for DamID-seq Data 
 
  Since DamID-seq is a novel source of sequencing data, we could not use existing ChIP-
seq peak callers to identify binding sites. One of the fundamental differences of DamID-seq is 
that only GATC sites in the genome carry measurable data. The distribution of GATC sites in the 
human genome is, in fact, not arbitrary. GATC sites are often less than 200bp apart (Figure 
4.1A), while a randomly distributed four-base motif would be expected every 256bp.  
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Figure 4.1. A New Peak Caller for DamID-seq Data 
(A) Distribution of distances between GATC sites in the human genome. The graph is truncated 
at 2000bp to show the distances with the highest frequencies. (B) Fold enrichment of GATC sites 
over the whole human genome for six aggregated state annotations. State annotations are based 
on nine histone modification maps in human K562 cells (Ernst, Kheradpour et al. 2011). (C) An 
interim peak caller that adapts Scripture for DamID by constructing a “GATC genome.” The 
reads at GATC sites are concatenated into “chromosomes,” demarcated by regions >5kb that 
lack GATC sites. Scripture is run on this “GATC genome,” and enriched peaks are mapped back 
to the real genome. (D) Fold enrichment of Dam peaks, as called by the interim peak caller, over 
the whole human genome for six aggregated state annotations. State annotations are based on 
nine histone modification maps in human K562 cells (Ernst, Kheradpour et al. 2011). (E) A new 
log2 peak caller for DamID-seq data. DamID-seq tracks for RNF2, Dam control, and the log2 
ratio of RNF2/Dam are shown. The peak caller is based on the log2 ratio, and the resulting peaks 
are below the tracks. (F) For 2 kb bins across chromosome 19, density scatter plot comparing the 
natural log of number of GATCs with the log2 peak caller reads for CBX8. A low density of 
points is colored blue, and a high density of points is colored red. The correlation coefficient is 
indicated in red at the upper left-hand corner. (G) For 2 kb bins across chromosome 19, density 
scatter plot comparing the G+C percentage with the log2 peak caller reads for CBX8. A low 
density of points is colored blue, and a high density of points is colored red. The correlation 
coefficient is indicated in red at the upper right-hand corner. 
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Figure 4.1 (Continued).   	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To examine the distribution of GATC sites at different regions of the genome, we used 
genomewide chromatin state annotations for human K562 cells, which was derived from nine 
histone modification maps (Ernst, Kheradpour et al. 2011). We compared the location of GATC 
sites with these state annotations, which we aggregated into “promoters,” “transcribed regions,” 
“distal elements,” “Polycomb,” “heterochromatin,” and “repetitive/copy-number variants.” We 
found that GATC sites are nearly 3.5-fold enriched at heterochromatin, while they are depleted 
from elsewhere in the genome (Figure 4.1B). Thus, DamID-seq effectively gives more 
representation at heterochromatin regions. 
The second fundamental difference of DamID-seq is that the Dam protein itself may have 
an inherent bias for particular genomic regions (Vogel, Peric-Hupkes et al. 2007). To analyze the 
nature and extent of this Dam bias, we mapped the binding of the Dam protein alone using 
DamID-seq. We needed an interim peak caller to identify any enriched sites in this sample.  
We adapted Scripture, a peak caller that has successfully identified ChIP-seq enriched 
regions (Guttman, Garber et al. 2010), for DamID-seq data by collapsing the genome to a series 
of GATC sites only, or “GATC genome” (Figure 4.1C).  We demarcated this “GATC genome” 
into “chromosomes” whenever there was a region over 5000bp that lacked GATC sites. We then 
used Scripture to identify enriched peaks, and mapped these peaks back to the real genome. 
We compared these Dam enriched peaks to the K562 chromatin state annotations, 
normalized by GATC sites. We found that the Dam protein has roughly 4-fold depletion in 
Polycomb regions, and nearly 3-fold enrichment in repetitive regions or regions subject to copy-
number variation (Figure 4.1D). Bias existed at other genomic regions, but was not as 
pronounced. Thus, we must normalize any DamID-seq maps for chromatin proteins by the Dam 
protein. 	 ﾠ 113 
To account for both the uneven distribution of GATC sites in the genome and the 
inherent bias of the Dam protein, we developed a peak caller that uses the log2 of the ratio 
between the protein over the Dam alone (Figure 4.1E). We called peaks that were above a certain 
quantile for each protein, based on known literature. Visual inspection confirmed that these 
peaks correlate with enriched regions in the protein track, except when there is high enrichment 
in the Dam control track. 
We validated that the log2 peak caller accounts for the inherent GATC and GC bias in 
our method, as shown in Chapter 3. For 2kb bins across one representative chromosome, we 
compared the number of GATCs with the log2 peak caller reads by plotting a log-scale density 
scatter plot (Figure 4.1F). We found that the correlation coefficient was reduced to 0.054, 
indicating that the number of GATC sites no longer biases our read numbers when we process 
with the log2 peak caller. Similarly, when we compare the G+C percentage with the log2 peak 
caller reads (Figure 4.1G), we found that the correlation coefficient was reduced to -0.022, 
indicating that the G+C percentage no longer biases our read numbers. 
 
Validation of DamID-seq by Comparison with ChIP-seq 
 
  We mapped the binding of three chromatin proteins by both DamID-seq and ChIP-seq in 
K562 cells: EZH2, RNF2, and CBX8. Since ChIP-seq is an established method for mapping 
proteins, we used it to validate our DamID-seq method and peak caller. 
  By visual inspection, the DamID-seq tracks for EZH2, RNF2 and CBX8 correlate fairly 
well with their respective ChIP-seq tracks (Figure 4.2A). Many of the peaks seem to overlap 
between the two methods.  	 ﾠ 114 
 
 
 
Figure 4.2. Validation of DamID-seq by Comparison with ChIP-seq 
(A) DamID-seq tracks and peaks, as called by the log2 peak caller, and ChIP-seq tracks and 
peaks, as called by Scripture, for EZH2, RNF2, and CBX8. (B) Venn diagram of 2 kb windows, 
excluding windows with less than 2 or greater than 10 GATC sites and accounting for adjacent 
windows, according to overlap with DamID-seq peaks (purple), ChIP-seq peaks (peach), or both 
(overlap), for EZH2, RNF2, and CBX8. The area of overlap is proportional to the percentage of 
windows in each class. (C) Classification of ChIP-seq peaks for EZH2, RNF2, and CBX8 
according to whether they 1) overlap with DamID-seq peaks (blue), 2) are within 5 kb of a 
DamID-seq peak (red), or 3) are greater than 5kb of a DamID-seq and therefore “undetected” by 
DamID-seq (green). Numbers under the bars represent the total number of peaks called. (D) 
Classification of DamID-seq peaks for EZH2, RNF2, and CBX8 according to whether they 1) 
overlap with ChIP-seq peaks (blue), 2) are within 5 kb of a ChIP-seq peak (red), or 3) are greater 
than 5kb of a ChIP-seq and therefore “novel” (green). Numbers under the bars represent the total 
number of peaks called. (E) Percentage of peaks overlapping H3K27me3 for EZH2, RNF2, and 
CBX8 according to whether they were detected by 1) ChIP-seq only (green), 2) both ChIP-seq 
and DamID-seq (blue), or 3) DamID-seq only (red). 
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Figure 4.2 (Continued). 	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Some of the called peaks have different lengths or slightly shifted locations, which may be due to 
the uneven distribution of GATC sites. Overall, there appears to be consistency between the two 
methods. 
To quantify the correlation between DamID-seq and ChIP-seq systematically across the 
genome, we divided the genome into 2 kb windows, and identified windows that overlapped with 
DamID-seq peaks, ChIP-seq peaks, or both (Figure 4.2B). We excluded windows that contained 
less than 2 or greater than 10 GATC sites, as that is the range of detection for DamID-seq. We 
also counted adjacent windows in the overlap percentage. For EZH2, we found that 56% of 
13876 ChIP-seq windows, and 33% of 20847 Dam-seq windows, overlapped windows of the 
opposite technology. For RNF2, the overlap contained 73% of 96232 ChIP-seq windows and 
63% of 100272 DamID-seq windows, and for CBX8, 71% of 63757 ChIP-seq windows and 44% 
of 103596 DamID-seq windows. Thus, both methods have respectable overlap on a 2 kb scale. 
  To examine whether the overlap between the ChIP-seq and DamID-seq windows are 
statistically significant, we performed a hypergeometric test. We found that for EZH2, the 
overlap between the two methods is significant, with a p-value of 2.57x10
-9. Similarly, for RNF2 
and CBX8, the p-values were both less than 1x10
-9. Therefore, the overlap between the peaks 
called by the two technologies on a 2kb scale is statistically significant. 
Since neither DamID-seq nor ChIP-seq peaks consistently correlate with 2 kb windows, 
we then examined the overlap on the basis of each ChIP-seq peak (Figure 4.2C). Of the 6562 
peaks called in EZH2 by ChIP-seq, about 31% overlap with DamID-seq peaks, and an additional 
20% are within 5 kb of a DamID-seq peak. Thus, about 51% of the ChIP-seq data can be 
accounted for by DamID-seq. The overlap is greater for RNF2 and CBX8. Of the 38085 peaks 
called in RNF2 by ChIP-seq, roughly 50% directly overlap, and an additional 20% are within 	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5kb, of DamID-seq peaks. Of the 37863 CBX8 peaks called by ChIP-seq, roughly 59% directly 
overlap, and an additional 22% are within 5kb, of DamID-seq peaks. Thus, over 70% and over 
80% of ChIP-seq peaks can be accounted for by DamID-seq in RNF2 and CBX8, respectively. 
This suggests that DamID-seq can account for more ChIP-seq peaks when performed on 
proteins that cover a greater percentage of genome. The mean ChIP-seq peak length for EZH2, 
RNF2, and CBX8 is 3116bp, 3659bp, and 4586bp, respectively. Thus, it also appears that 
DamID-seq can better account for ChIP-seq peaks if they are longer in length. This makes sense 
given that DamID-seq has a lower resolution compared to ChIP-seq, and depends on the 
distribution of GATC sites. Therefore, we recommend using DamID-seq on proteins with 
expected broad binding patterns. 
We next examined whether DamID-seq identifies novel peaks that are not found by 
ChIP-seq (Figure 4.2D). Of the 18449 peaks called in EZH2 by DamID-seq, about 14% overlap 
with ChIP-seq peaks, and an additional 11% are within 5kb of a ChIP-seq peak. Therefore, 75% 
of DamID-seq peaks for EZH2 in K562 cells are novel. For RNF2, of the 80700 DamID-seq 
peaks, about 33% overlap with ChIP-seq peaks, an additional 19% are within 5kb, and 48% are 
novel. For CBX8, of the 105808 DamID-seq peaks, 35% overlap, and another 20% are within 
5kb of, ChIP-seq peaks, while 44% are novel. 
We then asked whether the novel DamID-seq peaks were false positives or not. We used 
the H3K27me3 histone modification state as a proxy for true binding peaks, since it is known 
that Polycomb catalyzes this mark (Kerppola 2009). We examined the percentage overlap with 
H3K27me3 for peaks detected by ChIP-seq only, DamID-seq only, or both methods. For EZH2, 
we found that while 73% of peaks detected by both methods overlapped with H3K27me3, 64% 
of peaks detected solely by DamID-seq overlapped this mark. This percentage is the same as that 	 ﾠ 118 
for peaks detected solely by ChIP-seq. This suggests that over 87% of novel DamID-seq peaks 
are real, and that DamID-seq has a similar accuracy as ChIP-seq. For RNF2, 50% of peaks 
detected by both methods overlapped H3K27me3, while 37% of DamID-seq peaks and 32% of 
ChIP-seq peaks overlapped this mark. Here, at least 74% of novel DamID-seq peaks appear 
accurate; in this case, DamID-seq may be even more reliable than ChIP-seq. Finally, for CBX8, 
55% of peaks detected by both methods, 30% of peaks detected by DamID-seq only, and 41% of 
peaks detected by ChIP-seq only, overlapped with H3K27me3. Of the three proteins we 
compared, the accuracy of novel DamID-seq peaks for CBX8 appears the least accurate (over 
54%). However, this protein’s peaks had the most overlap between the two methods (over 80%), 
so it seems reasonable that the few outlying novel peaks may be more likely to be false positives 
compared to the other two proteins. Overall, it appears that the large majority of novel DamID-
seq peaks are real, and the accuracy of our method is similar to ChIP-seq, for all proteins we 
examined.          
There are several potential explanations for the novel peaks identified by DamID-seq. 
First of all, since DamID-seq relies on enzyme activity over 3 days, while ChIP-seq relies on 
formaldehyde crosslinking within 10 minutes, DamID-seq may be able to identify additional 
domains of enrichment. For instance, a Dam-fused protein that is loosely or transiently bound to 
its targets can still methylate adenines at nearby GATC sites, while formaldehyde may be unable 
to crosslink these regions within a 10-minute timeframe. Secondly, since DamID-seq is based on 
a fusion protein, rather than an antibody as in ChIP-seq, it is possible that it is able to detect 
binding in areas that may be inaccessible to antibodies, such as regions of high compaction. 
Thirdly, DamID-seq is subject to potential artifacts resulting from the protein’s fusion to Dam. 
This exogenous fusion protein may have binding sites that are neither reflected in the 	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endogenous protein nor accounted for by the Dam only control. It may also compete with the 
endogenous protein to skew the canonical function of the protein in the cell. Finally, the DamID-
seq peaks were called by the log2 peak caller, wile ChIP-seq peaks were called by Scripture. An 
independent, positive control for the protein’s true binding sites, additional sequencing reads for 
the DamID-seq maps, and further refinement of the statistical peak caller may help distinguish 
between these different explanations. 
 
DamID-seq Maps Genomewide Binding of 12 Chromatin Proteins 
 
We used DamID-seq to map the genomewide binding of EZH2, BMI1, RNF2, CBX1, 
CBX2, CBX3, CBX5, CBX6, CBX7, CBX8, UHRF1, and LMNB1 (Figure 4.3A). For 
comparison, we also included the ChIP-seq maps of histone modifications H3K27me3 and 
H3K9me3. We used our log2 peak caller to identify enriched peaks for each protein. The percent 
of genome covered by peaks for each protein was roughly 5%, except for EZH2 (0.7%), BMI1 
(0.4%), and LMNB1 (8.3%). 
By visual inspection, we found that the DamID-seq tracks for these proteins tended to 
look similar to either H3K27me3 or H3K9me3. CBX1 and CBX2 seemed to have qualities of 
both histone modification patterns. 
To begin to study the correlation between different proteins more systematically, we 
made scatter plots comparing two proteins at a time using 2kb bins across the genome (Figure 
4.3B).  
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Figure 4.3. DamID-seq Maps of 12 Chromatin Proteins 
(A) DamID-seq tracks of Polycomb proteins EZH2, BMI1, RNF2, CBX6, CBX7, CBX8 (blue), 
Polycomb protein CBX2 and heterochromatin protein CBX1 (light blue), heterochromatin 
proteins CBX3, CBX5, UHRF1, LMNB1 (red), and Dam only control (black). Interspersed are 
ChIP-seq tracks of histone modifications H3K27me3 (green) and H3K9me3 (purple). (B) Scatter 
plots comparing 2 kb bins of reads for indicated DamID-seq maps. The red number in the upper 
left corner is the correlation. 
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We found the highest correlations between members of the Polycomb group: RNF2 had a 
correlation of 0.8 with BMI1, 0.76 with EZH2, 0.76 with CBX6, 0.75 with CBX7, and 0.71 with 
CBX8. The correlation between RNF2 and CBX2 and CBX1 was much less: 0.61 and 0.42, 
respectively. CBX3 and CBX5, both dHP1 homologs, had a strong correlation: 0.74. The 
correlation between CBX3 and UHRF1 and LMNB1 was much less: 0.59 and 0.45, respectively. 
Again, it appears that CBX2 and CBX1 have unexpected binding patterns, given their homology 
to dPc and dHP1, respectively. 
 
Chromatin Proteins Cluster into Two Major Modules 
 
  To systematically compare the 12 chromatin proteins with each other, we present a 
matrix of correlations between each protein and the histone modifications, H3K27me3 and 
H3K9me3 (Figure 4.4A). We find that our set of chromatin proteins cluster into two major 
modules: 1) those that are members of Polycomb complexes, and 2) those that bind to 
heterochromatin. Surprisingly, CBX2, which is a homolog of dPc, clustered with 
heterochromatin proteins. 
  The Polycomb cluster proteins (EZH2, CBX6, CBX7, CBX8, RNF2, and BMI1) have 
strikingly high correlations with each other (Figure 4.4A). They are also all positively correlated 
with H3K27me3. This is expected since EZH2 is the catalytic subunit of Polycomb repressive 
complex 2 (PRC2), which methylates H3K27. Additionally, RNF2, BMI1, CBX6, CBX7, and 
CBX8 are all members of Polycomb repressive complex 1 (PRC1), which can recognize 
H3K27me3. It appears that in K562 cells, the targets of these two complexes are quite similar. 
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Figure 4.4. Chromatin Proteins Cluster into Two Major Modules 
(A) Matrix of correlations between the 12 DamID-seq protein maps, ChIP-seq of H3K27me3, 
and ChIP-seq of H3K9me3. The black boxes demarcate the Polycomb cluster and the 
heterochromatin cluster. (B) Pie charts for Polycomb cluster proteins EZH2, BMI1, RNF2, 
CBX6, CBX7, and CBX8 showing the percentage of peaks in six aggregated state annotations: 
promoters (orange), transcribed regions (blue), distal elements (black), Polycomb (yellow), 
heterochromatin (red), and repetitive/copy-number variants (green). State annotations are based 
on nine histone modification maps in human K562 cells (Ernst, Kheradpour et al. 2011). (C) Pie 
charts for heterochromatin cluster proteins CBX1, CBX3, CBX5, UHRF1, LMNB1, and CBX2 
showing the percentage of peaks in six aggregated state annotations: promoters (orange), 
transcribed regions (blue), distal elements (black), Polycomb (yellow), heterochromatin (red), 
and repetitive/copy-number variants (green). State annotations are based on nine histone 
modification maps in human K562 cells (Ernst, Kheradpour et al. 2011). 
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Figure 4.4 (Continued). 
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  The heterochromatin cluster proteins (CBX1, CBX5, CBX3, UHRF1, CBX2, and 
LMNB1) have greater differences between each other (Figure 4.4A). Interestingly, CBX3, 
CBX5, and LMNB1 are positively correlated with H3K9me3, while CBX1, CBX2, and UHRF1 
are not. As CBX1, CBX3, and CBX5 are all homologs of dHP1, it appears that CBX1 has 
diversified from the other two. UHRF1 has been previously reported to bind H3K9me3 (Rush, 
Cho et al. 2002), but the correlation seems to be weak in K562 cells. CBX2 surprisingly 
correlated best with UHRF1, and has clearly diverged in function from the other CBX proteins 
that are dPc homologs. 
  To characterize the binding targets of the 12 chromatin proteins, we compared the 
DamID-seq peaks of each with genomewide chromatin state annotations for K562 cells (Ernst, 
Kheradpour et al. 2011), which we aggregated into “promoters,” “transcribed regions,” “distal 
elements,” “Polycomb,” “heterochromatin,” and “repetitive/copy-number variants.” These state 
annotations are based on ChIP-seq maps of histone modifications, rather than chromatin proteins. 
  For the Polycomb cluster, we found that all proteins bound a large proportion of the 
“Polycomb state” (Figure 4.4B). While only 9% of the genome is in the “Polycomb state,” 66% 
of EZH2 and 64% of BMI1 peaks are in this state. These values constitute 7.3- and 7.1-fold 
enrichments, respectively. The other Polycomb cluster proteins also show great enrichment for 
this state. Specifically, 44% of RNF2 peaks, 39% of CBX6 peaks, 34% of CBX7 peaks, and 43% 
of CBX8 peaks are in the “Polycomb state.” These values are all at least 3.8-fold enriched over 
background. Thus, the Polycomb proteins we mapped with DamID-seq seem to be going to 
expected locations as defined by ChIP-seq of histone modifications. 
  For the heterochromatin cluster, we found that all proteins bound a large proportion of 
the “heterochromatin state” (Figure 4.4C). Notably, 58% CBX3, 61% of CBX5, and 92% of 	 ﾠ 126 
LMNB1 targets are in this state, while only 19% of the genome is in this state. These values 
constitute a 3.0-, 3.2-, and 4.8-fold enrichment over background. CBX1, CBX2, and UHRF1 all 
had modest enrichment for the heterochromatin state, and had minor enrichment for the 
Polycomb state as well. Specifically, 39% of CBX1 peaks, 32% of CBX2 peaks, and 35% of 
UHRF1 peaks were in the “heterochromatin state.” The “Polycomb state” accounted for 18%, 
24%, and 14% of these protein’s peaks, respectively. This translates to at least a 1.7-fold 
enrichment of the “heterochromatin state” and 1.6-fold enrichment of the “Polycomb state” for 
these three proteins. This again highlights the diversification of CBX1 and CBX2 from their 
homologous proteins.  
 
Polycomb Cluster: EZH2, BMI1, RNF2, CBX6/7/8 Bind Developmental Genes 
 
  To explore the functional significance of the binding patterns of these chromatin proteins, 
we identified the genes located under the binding peaks for each of the DamID-seq protein maps, 
and performed Gene Ontology enrichment analysis (Table 4.1). We found great redundancy in 
the gene targets of the Polycomb proteins EZH2, BMI1, RNF2, CBX6, CBX7, and CBX8, and 
examined their gene targets as a whole.  
We found that the Polycomb proteins bind genes involved in development and 
localization with a p-value of less than 10x10
-7 (Table 4.1). Examples of these genes include the 
HOXC cluster, NEUROD2, and GNAS (Figure 4.5A). The Hox locus contains clusters of genes 
and non-coding RNA involved in embryonic development (Rinn, Kertesz et al. 2007; Tschopp 
and Duboule 2011).  	 ﾠ 127 
 
Table 4.1. Gene Ontology Enrichment Analysis 
Enriched GO terms for gene targets of Polycomb cluster proteins (EZH2, BMI1, RNF2, CBX6, 
CBX7, CBX8), heterochromatin cluster proteins (CBX1, CBX3, CBX5, UHRF1, LMNB1), 
CBX1/3/5, UHRF1, LMNB1, and CBX2. The Benjamini-corrected p-value and the -log10 p-
value are shown. 	 ﾠ 128 
 
 
 
 
 
 
 
Figure 4.5. Gene Targets of Polycomb and Heterochromatin Proteins 
(A) DamID-seq maps of Polycomb proteins EZH2, BMI1, RNF2, CBX6, CBX7, and CBX8 at 
the HOX cluster containing HOXC13, HOXC12, lincRNA HOTAIR, and HOXC11; and genes 
NEUROD2 and GNAS. (B) DamID-seq maps of heterochromatin proteins CBX1, CBX3, CBX5, 
and UHRF1 at OR cluster containing OR7D2, OR7D4, and OR7E24; gene SCNN1G; and ZNF 
cluster containing ZNF223, ZNF284, ZNF224, and ZNF225. (C) DamID-seq maps of CBX2 at 
genes DOLPP1, ZER1, and QTRT1. 
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NEUROD2 is thought to determine and maintain the neuronal lineage during cell differentiation, 
and GNAS is known for its complex imprinting patterns (Messmer, Shen et al. 2012; Robson, 
Eaton et al. 2012). These results are consistent with previous reports that Polycomb is involved 
in repressing and poising developmental genes (Zhou, Goren et al. 2011). 
We note that the Polycomb proteins exhibit relatively sharp binding peaks, rather than 
broad domains (Figure 4.3; Figure 4.5A). In the three above examples, the Polycomb proteins 
bind with strong peaks at the promoter, across the body, or at the 3’UTR of its targets. This may 
reflect the tight regulation of Polycomb localization. 
 
Heterochromatin Cluster: CBX1/3/5 Bind Broad OR and ZNF Domains 
 
As a whole, the gene targets of the heterochromatin proteins (CBX1, CBX3, CBX5, 
UHRF1, LMNB1) did not give remarkable GO enrichments (Table 4.1). The few significant 
terms, such as cytoplasm and protein binding, were very general and of low overlap. It appears 
that the heterochromatin proteins we mapped have different target genes. Thus, we examined the 
GO enrichments for genes of these proteins separately.  
CBX1, 3, and 5 all bind a common pool of gene targets, despite the seeming diversity of 
CBX1 from the other two. These three dHP1 homologs bind genes involved in sensory 
functions; this is significant with a p-value of less than 10
-24 (Table 4.1). For instance, they coat 
the length of the OR gene cluster containing OR7D2, OR7D4, and OR7E24, as well as SCNN1G 
(Figure 4.5B). Olfactory receptors comprise a large family of genes that initiate a neuronal 
response that triggers smell, and SCNN1G is a subunit of a non-voltage-gated sodium channel 
(Malnic, Godfrey et al. 2004). In addition, CBX1/3/5 targets genes involved in ion and metal ion 	 ﾠ 131 
binding (Table 4.1). For instance, they bind the zinc finger (ZNF) cluster that includes ZNF223, 
ZNF284, ZNF224, and ZNF225. ZNF genes encode a large family of zinc finger proteins that 
bind zinc ions and are involved in transcriptional gene regulation (Lorenz, Dietmann et al. 2010). 
This finding is consistent with maps that show that CBX1 binds KRAB-ZNF genes in MCF7 
human breast carcinoma cell lines (Vogel, Guelen et al. 2006). 
Like CBX1/3/5, UHRF1 also binds genes that are involved in sensory functions, such as 
OR clusters and SCNN1G (Table 4.1; Figure 4.5B). However, it does not seem to bind to ZNF 
clusters or genes involved in ion and metal ion binding. 
LMNB1’s gene enrichments are very general, such as membrane and membrane part 
(Table 4.1). Indeed, most of LMNB1 binding is in regions of the genome that are gene poor. Its 
binding domains are extremely broad, and confirm previous reports that LMNB1 defines 
Megabase domains (Guelen, Pagie et al. 2008). 
It is notable that unlike Polycomb proteins, heterochromatin proteins bind broad domains 
that can be Megabases in length (Figure 4.3; Figure 4.5B). Both of CBX1/3/5’s notable gene 
targets, OR and ZNF genes, are members of large gene families that occur in broad clusters. This 
may reflect the role of heterochromatin in structurally sequestering large expanses of genome. 
 
CBX2 Binds Unique Gene Targets 
 
Since CBX2 seems to have diversified binding patterns compared to the other Polycomb 
proteins, we examined whether these differences are reflected in its gene targets. We found that 
indeed, CBX2 has unique gene targets beyond those of the other Polycomb proteins.  
Specifically, CBX2 is enriched at genes that are involved with modifying proteins and 	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binding adenyl ribonucleotide or ATP with a p-value of less than 0.00011 (Table 4.1). Examples 
of these genes include DOLPP1, ZER1, and QTRT1 (Figure 4.5C). Dolichyl pyrophosphate 
phosphatase 1 (DOLPP1) is an enzyme that is thought to play a role in recycling dolichyl 
pyrophosphate during reactions in the endoplasmic reticulum (Rush, Cho et al. 2002). ZER1 is a 
little studied protein that is thought to help recruit the E3 ubiquitin ligase complex ZER1-CUL2-
Elongin BC to its targets (Kim, Bennett et al. 2011). As a third example, queuine tRNA-
ribosyltransferase 1 (QTRT1) is the catalytic subunit of RNA-guanine transglycosylase, which 
modifies tRNAs (Chen, Brooks et al. 2011). Thus, CBX2 may play a unique role as a PRC1 
component involved in cellular enzymatic reactions. 
We note that CBX2, like the other Polycomb proteins, exhibits punctate binding peaks, 
rather than broad domains (Figure 4.3; Figure 4.5C). In the three above examples, CBX2 binds at 
the 3’ UTR of DOLPP1, the first intron of ZER1, and the promoter of QTRT1. Thus, it also 
appears that CBX2 can bind at any location in its target genes. Knockdown studies of CBX2 in 
mammalian cells are needed to address whether it can functionally repress genes regardless of 
binding location. 
 
DISCUSSION 
 
  Here, we presented the application of our DamID-seq technology to map the genomewide 
binding of 12 chromatin proteins in human K562 cells, and offered a novel peak caller for 
identifying binding domains from such data. We envision that DamID-seq, which is able to map 
broadly and loosely bound chromatin proteins, will complement ChIP-seq, which is better suited 
for mapping histone modifications and transcription factors, to comprehensively characterize 	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chromatin in mammalian cells. 
  In general, ChIP-seq may be a better choice for proteins that it can readily map, such as 
transcription factors and DNA-binding proteins. ChIP-seq measures binding within 10 minutes 
and has a resolution of 25bp, while DamID-seq measures binding within 3 days and has a 
resolution of 1kb or greater. Furthermore, ChIP-seq measures the endogenous protein, while 
DamID-seq measures an exogenous fusion protein, though it is lowly expressed. At this time, 
ChIP-seq has also been developed for small cell numbers and has been performed on as low as 
10
4 cells (Adli, Zhu et al.); DamID-seq has only been performed on 10
6 cells, though no attempt 
has been made yet to find the lower limit for this technology. 
  However, ChIP-seq is unable to map proteins without high-quality antibodies, most 
loosely, transiently, or broadly bound proteins, proteins in regions of compact chromatin, and 
mutant proteins. In these cases, DamID-seq may be uniquely able to provide genomewide 
mapping data. This is because DamID-seq does not rely on antibodies, crosslinking, or the 
solubility of chromatin. Furthermore, DamID-seq takes a reduced representation of the genome; 
specifically, it only reads GATC sites. Thus, it can map broadly distributed proteins with fewer 
sequencing reads. Finally, DamID-seq is not subject to crosslinking artifacts or antibody cross-
reactivity, which affects ChIP-seq experiments. 
  Our DamID-seq maps of 12 chromatin proteins reveal two major modules: 1) Polycomb-
related, and 2) heterochromatin-related. The PRC2 component EZH2, and the PRC1 components 
BMI1, RNF2, CBX6, CBX7, and CBX8 all bind a common set of developmental gene targets 
that is consistent with previous reports (Zhou, Goren et al. 2011). In contrast, heterochromatin 
proteins CBX1/3/5 bind OR and ZNF genes, which both occur in broad clusters in the genome 
(Malnic, Godfrey et al. 2004; Lorenz, Dietmann et al. 2010).  	 ﾠ 134 
Surprisingly, our maps show that the PRC1 component CBX2 exhibits unique binding to 
genes involved with modifying proteins, and may play a role in regulating cellular enzymatic 
reactions. CBX2 has been implicated in the repression of ovarian development in XY gonads by 
regulation of SRY, and in the maintenance of chromosome stability in the mammalian germline 
(Baumann and De La Fuente 2011; Yap and Zhou 2011). Interestingly, it is the only CBX 
protein that does not co-elute with RING1 in tandem affinity purification studies (Vandamme, 
Volkel et al. 2011). However, the role of CBX2 in mammalian somatic cells is yet to be studied. 
Our analyses suggest that knockdown of CBX2 in K562 cells may elucidate whether it plays an 
additional role in critical cellular enzymatic reactions in somatic cells. 
Since the structure of CBX2 is so similar to other CBX proteins, one may question why it 
would exhibit unique binding patterns (Yap and Zhou 2011). We note that CBX1 and CBX5 
have been found to have varying binding patterns depending on humoral signals and 
microenvironmental cues (Ritou, Bai et al. 2007), and such factors may also affect the binding of 
CBX2. Additionally, the chromodomain of CBX2 may be subject to post-translational 
modifications and nucleic acid binding, which would also alter the protein’s binding patterns 
(Yap and Zhou 2011). Furthermore, temporal changes, such as those due to the cell cycle and 
cell differentiation, add additional complexity to interpreting the DamID-seq maps, which reveal 
composite binding over three days. Thus, additional mechanistic studies are needed to reveal the 
conditions in which CBX2 displays unique binding. 
Our findings support a model in which the genome is organized into large domains, with 
Polycomb proteins repressing developmental genes at bodies, and heterochromatin proteins 
sequestering broad OR and ZNF clusters near the nuclear lamina. The Polycomb and 
heterochromatin domains appear to exhibit distinct properties. While Polycomb domains appear 	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more punctate, and may be more susceptible to local binding changes (as in the case of CBX2), 
heterochromatin domains appear broader, and may be more stable (as in the case of CBX1/3/5). 
These findings may be just the beginning of an appreciation of the distinct properties of higher-
order domains. 
 
METHODS 
 
Plasmid Construction 
 
We obtained plasmids pLgw V5-EcoDam (Dam only negative control), pLgw EcoDam-
V5-RFC1 (N-terminus Dam vector), pLgw RFC1-V5-EcoDam (C-terminus Dam vector), and 
pLgw CBX1-V5-EcoDam (CBX1-Dam positive control) from the Bas van Steensel laboratory. 
We obtained ORFs in plasmid pDONR221 (or pDONR201) for CBX2 (cloneID 
HsCD00080034), CBX3 (cloneID HsCD00296031), CBX5 (cloneID HsCD00079893), CBX6 
(cloneID HsCD00045684), CBX7 (HsCD00079712), CBX8 (cloneID HsCD00079972), EZH2 
(cloneID HsCD00039865), BMI1 (cloneID HsCD00000297), RNF2 (cloneID HsCD00044984), 
UHRF1 (cloneID HsCD00079664) and LMNB1 (clone ID HsCD00043675) from the PlasmID 
collection at the Dana-Farber/Harvard Cancer Center DNA Resource Core. 
  We used Invitrogen Gateway® Cloning technology to clone these ORFs into either pLgw 
EcoDam-V5-RFC1 (N-terminus Dam vector) or pLgw RFC1-V5-EcoDam (C-terminus Dam 
vector), depending on whether the available ORF had a stop codon. Namely, these proteins were 
cloned with an N-terminus Dam: CBX3, CBX6, BMI1, RNF2, and LMNB1. These proteins were 
cloned with a C-terminus Dam: CBX1, CBX2, CBX5, CBX7, CBX8, EZH2, and UHRF1. 	 ﾠ 136 
 
Cell Culture 
 
293T cells were grown according to standard protocols in Gibco KO DMEM media 
supplemented with 10% fetal bovine serum (FBS, Atlas Biologicals, F-0500-A), 1% 
Penicillin/Streptomycin (Invitrogen, 15140122), and 1% Glutamax. K562 erythrocytic leukemia 
cells (ATCC CCL-243) were grown according to standard protocols in RPMI 1640 media 
(Invitrogen, 22400105) supplemented with 10% fetal bovine serum (FBS, Atlas Biologicals, F-
0500-A) and 1% Penicillin/Streptomycin (Invitrogen, 15140122). 
 
Lentiviral Production and Infection 
   
293T cells were grown in 15cm dishes until 60-80% confluence. 1140uL of DMEM was 
combined with 60uL of Fugene. After 5 min, the following three plasmids were added: Gag, pol 
and rev plasmid (6ug), VSV envelope plasmid (3ug), and specific cloned Dam-protein plasmid 
or GFP (9ug). This mixture was incubated at room temperature for 5 min, then added dropwise 
to the 293T cells. After 8-12 hours, the media was replaced with 12mL fresh medium. After 72 
hours, the virus was collected filtered through 0.45 uM. The virus was ultracentrifuged at 28000 
rpm for 2 hours in an SW41Ti rotor at 4°C. The virus was resuspended in 100uL PBS, and left at 
4°C overnight. 
  K562 cells were counted with a hemacytometer and 1.5 million cells were allocated per 
each infection. Each aliquot of cells was spun down and resuspended in 3mL fresh media, and 
plated in one well of a 6-well plate. 2uL Polybrene (10mg/mL) and 30uL of concentrated virus 	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was added. The cells were spin-infected at 2500 rpm, for 90 min, at room temperature. The cells 
were then returned to 37°C overnight. 
  The following day, the infected cells were spun down and resuspended in 3mL fresh 
media. After 48 hours later, the cells were harvested and the gDNA was isolated using the 
Qiagen DNA Micro Kit, “Isolation of gDNA from Small Volumes of Blood” protocol. The DNA 
was eluted in 200uL buffer AE, and quantified by Nanodrop. 
 
DamID Library Preparation and Sequencing 
   
The gDNA was ethanol precipitated, and dissolved in TE pH7.5 to a concentration of 1 
ug/uL. 2.5uL of gDNA was digested with 0.5uL of DpnI (NEB, 20 U/uL) at 37°C overnight in 
PCR tubes. DpnI was inactivated by heating to 80°C for 20 min. The DpnI-digested gDNA was 
ligated with the adaptor AdR, which is made by mixing and slowly annealing AdR-top (5’ 
CTAATACGACTCACTATAGGGCAGCGTGGTCGCGGCCGAGGA 3’) and AdR-bottom (5’ 
TCCTCGGCCG 3’). This ligation was completed using 1uL T4 Ligase (Roche, 5U/uL) for 2 
hours at 16°C. The T4 ligase was inactivated by heating to 65°C for 10 min. The resulting 20uL 
volume reaction was diluted to 50uL with ddH2O. 
  To amplify the regions flanked by adaptors, the following PCR was setup: 10uL DNA, 
5uL 10x cDNA PCR reaction buffer (Clontech), 0.625uL primer bio-Adr-PCR (5’ bio-
GGTCGCGGCCGAGGATC 3’, 100uM), 1uL dNTPs (10mM), 1uL PCR advantage enzyme 
mix (Clontech, 50X), 32.375uL ddH2O. The PCR reaction program was as follows: 1 cycle of 
68°C (10min), 94°C (1min), 65°C (5min), 68°C (15min); 3 cycles of 94°C (1min), 65°C (1min), 
68°C (10min); 17 cycles of 94°C (1min), 65°C (1min), 68°C (2min). 5uL of the PCR products 	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were ran on a gel to verify successful digestion and amplification. 
  The PCR products were cleaned with the Qiagen MinElute PCR Purification kit, and 
eluted in 20uL ddH2O. Following quantification by Nanodrop, 3ug of each sample was diluted 
in 100uL ddH2O. These samples were sonicated with Covaris using the following settings: 10% 
duty cycle, 5 intensity, 200 cycles per burst, for 4.5 min total. 10uL of the Covaris-sonicated 
samples were ran on a gel to verify sonication to 100-500bp. 
  To pull down the biotinylated ends of the PCR products, we used Invitrogen Dynabeads® 
MyOne Streptavidin T1 beads. 50uL of these beads were washed three times with 50uL of 1X 
Binding and Washing (B&W) buffer (5mM Tris-HCl pH 7.5, 0.5mM EDTA, 1M NaCl). The 
washed beads were resuspended in 75uL of Covaris-sonicated DNA, 100uL of 2X B&W buffer, 
and 25uL H2O. This mixture was incubated at 4°C for 15min on a rotator. Following a quick 
spin and decanting the supernatant, the beads were washed three times with 200uL of 1X B&W 
buffer. 
  The bound DNA was removed off the beads by digestion with DpnII at 37°C for 1 hour. 
The supernatant was collected and cleaned using the Qiagen MinElute Reaction Cleanup kit. The 
resulting DNA was eluted in 20uL H2O and quantified with Qubit. qPCR analysis was 
performed to validate the DamID DNA before submission for sequencing. 
  Libraries of DamID samples were prepared according to the Illumina Genomic DNA 
protocol, as described previously (Mikkelsen et al., 2007). The DamID-seq libraries were 
sequenced on Illumina GAII sequencers according to standard Illumina protocols. 
 
DamID-seq Data Analysis 
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Sequence reads were aligned to the human genome reference (hg19). We filtered out low-
quality reads, and filtered in reads that map to GATC sites. The number of reads was counted at 
each GATC site. The reads were viewed using the Integrative Genomics Viewer 
(http://www.broadinstitute.org/igv/). 
For our interim peak caller, these counts were translated to a “GATC genome,” which 
was made by concatenating GATC sites only. This “GATC genome” was demarcated into 
“chromosomes” whenever there was a region over 5000bp that lacked GATC sites. Scripture was 
used to segment the Dam data into enriched peaks, and these peaks were translated back to the 
real genome. 
For our log2 peak caller, we scanned the genome using a sliding window of 2500bp, with 
a 250bp step size, and computed a score as follows: log2((protein count + 1)/(Dam count +1)). 
The 250bp at the center of the window was marked as a peak if the score exceeded a given 
threshold. Thresholds were established for each protein based on known literature and respective 
ChIP-seq maps if available. Specifically, the following thresholds were used: 2.25 (CBX3, 
CBX5, LMNB1), 2.5 (CBX1, CBX2), 2.7 (UHRF1), 3.0 (CBX8), 3.5 (CBX6), 3.7 (CBX7), 3.8 
(RNF2), 5.2 (EZH2), 5.7 (BMI1).  
To construct the correlation matrix, we first assembled the “world of Dam peaks,” or the 
total of all peaks from our DamID-seq K562 tracks. Then for every 2kb window in this 
foreground, we calculated the Pearson correlation between the counts for the given pair of 
proteins. We used hierarchical cluster analysis to assemble these correlations into the matrix. 
We used GoSTAT (http://gostat.wehi.edu.au/) to find statistically overrepresented Gene 
Ontology terms for genes called by DamID-seq peaks. We used the goa_human GO gene-
association database, a minimal length of 3 for considered GO paths, and corrected for multiple 	 ﾠ 140 
hypothesis testing with Benjamini. We displayed the top 5 (or less) GO terms that had a p-value 
of less than 0.05. 
 
Chromatin Immunoprecipitation Library Preparation and Sequencing 
 
Cells were crosslinked in 1% formaldehyde for 10 min at 37°C, and then quenched with 
glycine for 5 min at 37°C. Fixed cells were lysed in 1% SDS, 10mM EDTA and 50mM Tris-HCl 
pH 8.1 supplemented with protease inhibitor (Roche), fragmented with a Branson Sonifier 
(model S-450D) at 4°C to a size range between 200 to 800bp, and precipitated by centrifugation. 
5 to 10 ug of antibody was pre-bound by incubating with a mix of Protein-A and Protein-G 
Dynabeads (Invitrogen, 100-02D and100-07D, respectively) in blocking buffer (PBS 
supplemented with 0.5% TWEEN and 0.5% BSA) for 2 hr. Washed beads were added to the 
chromatin lysate, and then incubated overnight. Samples were washed 6 times with RIPA buffer, 
twice with RIPA buffer supplemented with 500 mM NaCl, twice with LiCl buffer (10 mM TE, 
250mM LiCl, 0.5% NP-40, 0.5% DOC), twice with TE (10Mm Tris-HCl pH 8.0, 1mM EDTA), 
and then eluted in 0.5% SDS, 300 mM NaCl, 5 mM EDTA, 10 mM Tris Hcl pH 8.0 at 65°C. 
Eluate was incubated at 65°C overnight, and then treated with RNaseA (Roche) for 30 min and 
Proteinase K (NEB) for 2hr. DNA was purified using a Qiagen DNA purification kit. 
Libraries of ChIP samples were prepared according to the Illumina Genomic DNA 
protocol, as described previously (Mikkelsen, Ku et al. 2007). The ChIP-seq libraries were 
sequenced on Illumina GAII sequencers according to standard Illumina protocols. 
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  “Chromatin” was coined by W. Flemming around 1880 to refer to “that substance in the 
cell nucleus which is readily stained,” as seen under the microscope (Olins and Olins 2003). 
Since the advent of molecular biology, we have focused on studying chromatin one loci at a 
time. Now, armed with technology to scale the study of molecular features to a genomewide 
level, we are once again facing the task of modeling the whole genome in nuclear space. 
 
SUMMARY AND SIGNIFICANCE 
   
  In this Thesis, we presented new frameworks for the study of mammalian chromatin 
organization (Chapter 1). These models highlight initial efforts to integrate genomewide 
information on histone modifications and chromatin proteins, and to merge these molecular 
insights with the three-dimensional organization of chromatin within the nucleus. We hope to 
spur development of new technologies to characterize higher-order chromatin structures with the 
goal of understanding genome regulation during differentiation, development, and disease. 
  We then advanced the understanding of Polycomb regulation by identifying GC-rich 
sequences that are necessary and sufficient for Polycomb repressive complex 2 (PRC2) 
recruitment in mammalian ES cells (Chapter 2). We also showed that the candidate transcription 
factor YY1 is not directly involved in PRC2 recruitment in these cells. Our findings on the 
determinants of Polycomb localization provide insight on the programming of gene expression in 
mammalian development. 
  Next, we adapted DamID for high-throughput sequencing, a method we called DamID-
seq. This technology generates genomewide maps of chromatin proteins without crosslinking 
and antibodies, and thus is able to profile broadly, loosely, and transiently bound proteins   148 
(Chapter 3). This method enables many previously unmappable proteins to be characterized in 
human cells for the first time. 
  We then used DamID-seq to map 12 chromodomain-containing and related proteins in 
K562 cells, and found that Polycomb proteins cluster together and bind developmental genes, 
while heterochromatin proteins cluster together and bind broad olfactory receptor and zinc finger 
domains (Chapter 4). We also identified CBX2 as a unique Polycomb protein that binds to genes 
involved with modifying proteins. These findings support the model of chromatin 
compartmentalization within the mammalian cell nucleus. 
  We note that in general, ChIP-seq may be a better choice for proteins that it can readily 
map, such as transcription factors and DNA-binding proteins, because it has a higher resolution, 
measures the endogenous protein, and has been performed on lower cell numbers. However, for 
the proteins that ChIP-seq is unable to map, including most chromatin proteins, DamID-seq may 
be uniquely able to provide genomewide mapping data. Furthermore, DamID-seq takes a 
reduced representation of the genome, thus requiring fewer sequencing reads to map broad 
proteins, and is not subject to crosslinking artifacts or antibody cross-reactivity (Chapter 4 
Discussion). 
  Finally, we used chromosome conformation capture (3C) technology to reveal looping 
interactions between enhancers and promoters during muscle cell differentiation (Appendix). 
Numerous technologies derived from 3C are currently at the forefront of characterizing the three-
dimensional organization of chromatin. We expect these and other methods to set the stage for a 
global understanding of chromatin in different cell types and disease states. 
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FUTURE DIRECTIONS 
 
  Based on the work in this Thesis, as well as other recent studies, a model for the three-
dimensional organization of chromatin is emerging. In general, it appears that active chromatin 
marked by H3K4me1, H3K4me2, H3K4me3, H3K36me3, H4K20me1, and H3 and H4 
acetylation is located in the center of the nucleus, and contains early replicating DNA (Ryba, 
Hiratani et al.). In contrast, inactive chromatin marked by H3K9me2 and H3K9me3 is located at 
the periphery of the nucleus, contacts the nuclear lamina, and contains late replicating DNA 
(Chapter 4) (Guelen, Pagie et al. 2008; Wen, Wu et al. 2009). 
  In addition, various specialized bodies seem to be located throughout the nuclear milieu. 
For instance, Polycomb bodies are thought to be discrete foci that contain Polycomb proteins, 
H3K27me3-marked chromatin, and silenced genes (Chapter 2; Chapter 4) (Hawkins, Hon et al. ; 
Sexton, Schober et al. 2007; Pauler, Sloane et al. 2009). Transcription factories are nuclear 
hotspots that contain 6 to 8 active polymerases, multiple active genes, and corresponding 
transcription factors (Schoenfelder, Sexton et al. ; Osborne, Chakalova et al. 2004; Misteli 2007). 
To further complicate the picture, there is evidence that each chromosome is located in a 
territory, the nucleolus has associated domains, and specific genomic regions can loop to come 
into contact (Appendix) (Nemeth, Conesa et al. ; Meaburn and Misteli 2007). It is intriguing to 
think that each cell type or disease state may have a unique three-dimensional chromatin 
organization that is particularly suited for its function. 
  Initial evidence already suggests that global chromatin structure reflects cell state and 
changes during cell differentiation. For instance, ES cells are characterized by globally open 
chromatin that is enriched in active marks and loosely associated with architectural proteins   150 
(Meshorer and Misteli 2006). Polycomb in ES cells poises developmental genes for rapid 
activation or repression upon differentiation, and buffers transcriptional noise to maintain 
pluripotency (Chapter 2) (Bernstein, Mikkelsen et al. 2006; Chi and Bernstein 2009). Indeed, 
remodeling chromatin seems to be one of the crucial changes during reprogramming (Ang, 
Gaspar-Maia et al. 2011; Onder, Kara et al. 2012). Thus, it would be interesting to use DamID-
seq to chart chromatin proteins in various cell types during differentiation. This would further 
test the model that cellular differentiation corresponds to global chromatin reorganization, and 
perhaps identify unique signatures for each cell type. 
  Furthermore, evidence suggests that chromatin structure reflects aberrant changes in 
diseased cells. For instance, Wilms tumor cells seem to have a similar chromatin landscape as 
renal stem cells, implying that they may originate from arrested development of these cells 
(Aiden, Rivera et al. 2010). Indeed, tumors in general seem to have gross changes in chromatin 
domains, as seen by histological changes evident within nuclei and the notable loss of LOCKs in 
cancer cell lines (Wen, Wu et al. 2009). Additionally, the three-dimensional structure of the 
genome affects the frequency of chromosomal translocations (Branco and Pombo 2006). For 
instance, two recent studies show that androgen-induced proximity of genomic loci may 
influence the frequency of aberrant fusion (Lin, Yang et al. 2009; Mani, Tomlins et al. 2009). 
Thus, it may be fruitful to use DamID-seq to map chromatin proteins in various disease states. 
As DamID-seq is able to chart mutant proteins by fusing the Dam enzyme to a mutated sequence 
of the protein, it may be particularly suited to study chromatin in disease models.  
  Currently, DamID-seq technology profiles a protein of interest in an ensemble of cells 
over three days. To detect rapid changes during differentiation or aberrant changes within a small 
cell population, greater sensitivity is needed. We note that for ChIP-seq, efforts are already   151 
underway to minimize the amount of starting material needed and improve the sensitivity of 
assays (Adli, Zhu et al. ; Goren, Ozsolak et al.). Analogous improvements to DamID-seq may 
bring us closer to characterizing chromatin proteins in small cell numbers. Additionally, since 
the Dam protein dynamically marks its binding sites in a living cell, it may one day be possible 
to track this footprint in real time using imaging. 
  Advancements in DamID-seq for characterizing chromatin proteins, along with new 
technologies for examining three-dimensional chromatin structure, may eventually lead us to 
reach the ultimate goal: to characterize chromatin structure for every individual cell at any time 
point. I speculate that in the future, the field may assemble a catalog of the three-dimensional 
chromatin organization of most cell types in the human body. We may even be able to track 
changes in this structure as cells differentiate; for instance, we may visualize chromatin 
compacting and moving towards the nuclear periphery as a pluripotent cell becomes specialized. 
Then by relating this chromatin structure to genome function, we will be able to interpret the 
human genome more fully. In parallel, researchers may also characterize chromatin organization 
in various disease states. By comparing these maps to those of healthy cells, one may be able to 
pinpoint aberrant changes, and better understand, detect, and treat disease. 
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ABSTRACT 
 
Identifying gene regulatory elements and their target genes in human cells remains a 
significant challenge. Despite increasing evidence of physical interactions between distant 
regulatory elements and gene promoters in mammalian cells, many studies consider only 
promoter-proximal regulatory regions. Cis-regulatory modules (CRMs) that are distant (>20 kb) 
from muscle gene promoters are common and are more likely than proximal promoter regions 
to show differentiation-specific changes in myogenic TF binding. We find that two of these 
distant CRMs, known to activate transcription in differentiating myoblasts, interact physically 
with gene promoters (PDLIM3 and ACTA1) during differentiation. Our results highlight the 
importance of considering distal CRMs in investigations of mammalian gene regulation and 
support the hypothesis that distant CRM-promoter looping contacts are a general mechanism of 
gene regulation. 
 
INTRODUCTION 
 
The identification of genomic sequence regions that regulate genes in a condition-specific 
manner is essential to understanding how the same genome sequence can give rise to the 
diversity of cell types and functions observed in an organism. In an organism with a small 
genome, such as yeast, the majority of gene regulation can be explained by transcription factor 
(TF) binding and chromatin modifications within approximately 600 bp to 1 kb of DNA 
sequence upstream of the regulated gene (Chua, Robinson et al. 2004; Zhu, Byers et al. 2009). In 
metazoans, numerous prior studies in a range of organisms from sea urchin to mammals have 	 ﾠ 157 
identified cis-regulatory modules (CRMs), consisting of clusters of TF binding sites, located next 
to (or within the introns of) the genes whose expression they regulate (Davidson 2001). 
However, as compared to the yeast genome, metazoan genomes, in particular mammalian 
genomes, have a much higher proportion of noncoding sequence, and recent research has 
highlighted the importance of more distant CRMs in gene regulation within these genomes 
(Dostie, Richmond et al. 2006; Kumaran, Thakar et al. 2008; Sexton, Bantignies et al. 2009). 
Much detailed work on distantly located transcriptional enhancers in Drosophila has shown the 
importance of such distant regulatory elements and the ways that they can be directed to their 
target genes by insulator boundaries and promoter targeting sequences (Lin, Lin et al. 2010). In 
mammalian systems, the rules governing enhancer–promoter links are less evident, but certain 
examples of distant regulatory elements have been studied in detail. For example, the locus 
control region (LCR) of themurine β-globin locus forms a GATA-1-dependent looping 
interaction with actively transcribed globin gene promoters located approximately 40–60 kb 
away in erythroid cells (Tolhuis, Palstra et al. 2002; Vakoc, Letting et al. 2005). Such results 
suggest that a complete understanding of gene regulation will require searching for CRMs distant 
from target genes and further studies of how these CRMs are directed to and regulate their target 
genes. 
The differentiation of human skeletal myoblasts into mature muscle fibers requires the 
coordinated regulation of many genes and is essential for the development and maintenance of 
proper muscle function. This differentiation process can be easily induced and monitored in cell 
culture, making it a tractable model system for investigating the regulatory mechanisms 
underlying dynamic, tissue specific gene expression in human. Prior studies have measured 
changes in gene expression and TF binding during differentiation in primary human skeletal 	 ﾠ 158 
muscle cells or in the similar C2C12 mouse skeletal muscle cell line (Bergstrom, Penn et al. 
2002; Blais, Tsikitis et al. 2005; Cao, Kumar et al. 2006; Warner, Philippakis et al. 2008; Cao, 
Yao et al. 2010). These studies have shown that a master regulatory TF, MyoD (encoded by 
MYOD1), initiates the cascade of gene regulation that leads to fusion of undifferentiated 
myoblast cells into multinucleated, elongated myotubes with developed contractile elements 
(Berkes and Tapscott 2005; Cao, Kumar et al. 2006). Other TFs in the myogenic regulatory 
factor (MRF) basic helix-loop-helix (bHLH) family – myogenin (MyoG, encoded by MYOG), 
Myf5 (MYF5), and MRF4 (MYF6) – some of which are activated directly by MyoD, work 
together with MyoD and other TFs such as Serum Response Factor (SRF) and the Myocyte 
Enhancer Factor 2 (Mef2) family to regulate the expression of genes involved in the continuation 
and completion of this differentiation process (Berkes and Tapscott 2005; Cao, Kumar et al. 
2006; Gianakopoulos, Mehta et al. 2011). Using the sets of differentially expressed genes, 
conservation of sequence across species, and the DNA binding site motifs of myogenic TFs, 
CRMs responsible for coordinating changes in expression during myogenic differentiation have 
been predicted computationally (Thompson, Palumbo et al. 2004; Sun, Chen et al. 2006; Warner, 
Philippakis et al. 2008). However, unlike the β-globin locus in which some of the classic distant 
regulatory interactions have been characterized previously, little is known about the role of 
distant regulatory modules in human skeletal muscle differentiation. 
Previous efforts to characterize the transcriptional regulatory network in skeletal muscle 
differentiation have measured binding of myogenic TFs using chromatin immunoprecipitation 
followed by microarray hybridization or sequencing (ChIP-chip or ChIP-Seq, respectively) in 
murine C2C12 cell lines (Blais, Tsikitis et al. 2005; Cao, Kumar et al. 2006; Cao, Yao et al. 
2010) and have tested the regulatory function of some predicted TF-bound elements with 	 ﾠ 159 
reporter assays (Sun, Chen et al. 2006). While the results of these studies have revealed 
previously unknown regulatory connections between TFs and differentiation processes, they 
tended to focus on TF binding near promoters (approximately 1–4 kb upstream of transcriptional 
start sites (TSSs)) (Blais, Tsikitis et al. 2005; Cao, Kumar et al. 2006; Sun, Chen et al. 2006). In 
contrast, methods to predict CRMs involved in myogenic differentiation have identified 
candidate regulatory modules by searching sequences up to 10 kb (Thompson, Palumbo et al. 
2004) or 50 kb (Warner, Philippakis et al. 2008) away from TSSs. A handful of the more 
distantly located predicted CRMs (approximately 20–30 kb upstream or downstream of TSSs) 
were found to activate expression in reporter assays specifically during myogenic differentiation 
and to be bound by myogenic TFs (Warner, Philippakis et al. 2008). These results suggest that 
gene regulatory myogenic TF binding occurs at locations distant from the proximal promoter 
regions that have been the focus of most prior studies. 
Here, we determined whether distant CRMs with no microRNA or protein-coding gene 
promoters nearby can form long-range looping interactions with muscle gene promoters. We 
examined two distant CRMs previously found to drive gene expression specifically during 
myogenic differentiation as case examples. We found that these CRMs form differentiation-
specific physical interactions with their closest target genes. Our results provide further support 
that a complete understanding of transcriptional regulation in mammals will require 
consideration of CRMs located distant from their target genes in the genome sequence. 
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RESULTS 
 
Differentiation-specific looping interactions between distant CRMs and muscle gene 
promoters 
 
We used Chromosome Conformation Capture (3C) (Dekker, Rippe et al. 2002; Hagege, 
Klous et al. 2007) experiments to investigate whether the putative myogenic CRMs that we 
found located distant from muscle genes form physical interactions with their adjacent, putative 
target genes during myogenic differentiation. We selected two CRMs that were bound by MyoG 
at 48 h after induction of differentiation, exhibited H3K4me1 and H3K27Ac enhancer-associated 
histone marks, were found to drive expression of a reporter gene during differentiation (Warner, 
Philippakis et al. 2008), and were located at least 20 kb away from the TSS of the closest known 
protein-coding gene. The “ACTA1 CRM” (Figure A.1A) is located 23 kb downstream of the 
TSS of ACTA1, a gene which encodes the skeletal muscle alpha actin protein, an essential part 
of the contractile element in muscle. The “PDLIM3/SORBS2 CRM” (Figure A.1B) is located 32 
kb upstream of PDLIM3, which encodes a cytoskeletal organizing protein localized to the Z line 
of the sarcomere and which may also regulate the myogenic differentiation transcriptional 
network by affecting the nuclear localization of SRF (Pomies, Pashmforoush et al. 2007). This 
CRM is also located 240 kb downstream of SORBS2, another gene differentially expressed 
during myogenic differentiation. 
To assay the physical interactions between these two CRMs and their adjacent genes, we 
performed 3C experiments on human muscle cells 48 h before, immediately (“0 h”) before, and 
48 h after induction of differentiation by serum removal.  	 ﾠ 161 
 
 
 
 
Figure A.1. 
3C evidence that CRMs physically interact with muscle gene promoters 20–35 kb away during 
(0 h and 48 h) but not before (−48 h) differentiation. The y-axis shows the normalized ratio 
between the average quantity of the interaction-specific ligation PCR product vs. the BAC 
control. To allow relative comparisons between experiments, this ratio is normalized such that 
the interaction frequency between the fixed primer (located at 0) and its neighboring fragment is 
1. Error bars=1 s.e.m. Restriction fragment boundaries are indicated above the graph. Note: not 
all restriction fragments are represented because some could not be assayed by good primers. (A) 
A 3C fixed primer at the ACTA1 promoter shows a significant interaction with a downstream 
CRM after, but not before, differentiation (p<0.05 by Student's t-test). (B) A 3C fixed primer at 
the CRM upstream of PDLIM3 shows a specific interaction with the PDLIM3 promoter after, 
but not before, differentiation (p<0.05 by Student's t-test). In both cases, the interaction is first 
established as the cells begin to differentiate (0 h) and then increases during differentiation (48 
h). 
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Figure A.1 (Continued).   	 ﾠ 163 
We identified “differentiation-specific interactions” by searching for any peaks of interaction in 
the 0 h or 48 h post-differentiation cells, outside of the neighboring +/−15 kb that may interact 
highly by random collisions with the fixed bait, that were higher than the 48 h pre-differentiation 
interaction level (see Materials and Methods). The results of these experiments show evidence 
for a differentiation-specific interaction between the “ACTA1 CRM” and the proximal promoter 
region spanning from 1.6 kb upstream to 1.3 kb downstream of the ACTA1 TSS (Figure A.1A). 
We confirmed this looping interaction in cells at 48 h post-differentiation using two different 
restriction enzymes, BglII and AflII (Figure A.2). We also found a differentiation-specific 
interaction between the “PDLIM3/SORBS2 CRM” and the region spanning from 3 kb upstream 
to 4 kb downstream of the PDLIM3 TSS (Figure A.1B). This interaction was observed in 
primary myoblasts obtained from two different individuals. 
The physical interactions between both of these previously identified CRMs (Warner, 
Philippakis et al. 2008) and their corresponding target gene promoters are absent 48 h before 
differentiation, but then become evident at 0 h, when the cells are confluent and elongating and 
differentiation is induced by serum removal. These CRM–promoter interaction peaks become 
more pronounced at 48 h after induction of differentiation (Figure A.1). These results suggest 
that a differentiation-induced chromosome conformation is established at these gene loci as the 
cells are approaching confluence and may be initiating the differentiation process even before 
stimulation of differentiation by serum removal. These physical interaction data parallel the 
previously published observation that the expression of the ACTA1 and PDLIM3 genes begins 
to increase from −48 h to 0 h (Warner, Philippakis et al. 2008) and our observations described 
above that predicted CRMs are often already bound by myogenic TFs at 0 h.  
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Figure A.2. 
The interaction at 48 h post-differentiation between the ACTA1 promoter and the CRM 25 kb 
downstream is confirmed by independent experiments with two restriction enzymes, AflII and 
BglII. AflII restriction sites are shown and narrow the region of the ACTA1 CRM interaction as 
compared to the BglII sites. 
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Interestingly, the PDLIM3/SORBS2 CRM was observed to interact only with the PDLIM3 
promoter region 23 kb downstream of the CRM but not with either of the two alternative 
promoters of SORBS2 located 240 kb and 385 kb upstream of the PDLIM3/SORBS2 CRM. 
Thus, while the PDLIM3/SORBS2 CRM acts on its target promoter over a distance, the CRM 
selectively interacts with the closer promoter rather than the farther promoter. These 
observations suggest a model in which distant enhancers participate in activating gene expression 
by looping to contact the promoters of the genes closest to them. Alternatively, the promoter 
selectivity could be due to promoter sequence elements that differ between genes to specify the 
appropriate interaction or cell-type specific insulator architecture (Dean 2011). 
 
DISCUSSION 
 
In this study we found a variety of evidence that CRMs involved in myogenic 
differentiation can be located distant from the proximal promoter regions of muscle genes. Here, 
we found that two of these predicted and validated CRMs, the ACTA1 CRM and the 
PDLIM3/SORBS2 CRM, both located more than 20 kb from muscle genes, interact with 
adjacent gene promoters as assayed by 3C. 
After distant CRMs are identified, a remaining challenge is to determine which genes 
they regulate and the mechanisms by which they affect gene expression. The differentiation-
specific interactions observed in this study by 3C for the CRMs located 20–35 kb away from 
ACTA1 and PDLIM3 suggest a model in which these distal enhancers assist in activating gene 
expression by looping to contact the promoters of the closest genes. These are the first such 
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differentiation. Combined with the mounting evidence of CRM–promoter interactions in other 
cell types and systems, these data suggest that long-distance physical interaction is a general 
mechanism of enhancer action rather than a mechanism specific to a particular system. That 
these enhancer–promoter interactions begin to form at 0 h of differentiation suggests that a 
differentiation-specific set of looping interactions may be established before the resulting 
changes in gene expression and cell phenotype begin. This is consistent with findings in other 
systems: in mouse erythroid progenitors, the β-globin LCR region exhibits interactions that are 
established before changes in gene expression occur (Phillips and Corces 2009), and interactions 
between enhancers and promoters implicated in hormone responsive gene expression in mouse 
adenocarcinoma cells are already present at lower levels before hormone treatment (Hakim, 
Sung et al. 2011).  
When identifying target genes for CRMs outside proximal promoter regions, some 
previous studies have used the simplifying assumption that CRMs are likely to interact with gene 
promoters lying within a domain bounded by CTCF sites, on the basis that CTCF often acts as an 
insulator across which boundary interactions are less likely to occur (Heintzman and Ren 2009; 
Cao, Yao et al. 2010). This assumption matches experimental results in the case of the 
PDLIM3/SORBS2 CRM, which interacts with the PDLIM3 promoter in the same CTCF domain 
(as measured by a previous study in human skeletal muscle myoblasts (Ernst, Kheradpour et al. 
2011)), but does not interact with the SORBS2 promoters that are separated from the CRM by 
several CTCF sites. However, the interaction we observed between the ACTA1 CRM and the 
ACTA1 promoter crosses a CTCF site, as does the interaction between the PDLIM3/SORBS2 
CRM and the predicted CRM located 27 kb upstream of a SORBS2 promoter. Thus, our results 	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suggest that the links between CRMs and their target genes cannot always be predicted 
accurately by CTCF sites. 
How enhancer–promoter interactions are established and why they are advantageous to 
myogenic differentiation are yet to be determined. It is possible that the myogenic TFs observed 
to bind to these interacting regions are also responsible for mediating these interactions. 
However, a full understanding of the interaction mechanism will require future work to search 
for sequence motifs recognized by other factors potentially involved in establishing 
chromosomal domains (CTCF, for example (Phillips and Corces 2009)), to experimentally purify 
factors associated with the interacting genomic regions (Dejardin and Kingston 2009), and to 
disrupt implicated DNA binding sites to test whether they are required for the physical 
interactions. 
This study demonstrates that CRMs for myogenic differentiation distant from muscle 
gene promoters can physically interact with their target genes. These results highlight the 
importance of looking beyond the proximal promoter to understand the transcriptional regulation 
of genes involved in differentiation. These distant CRM–promoter interactions may relate to the 
global changes in genome organization observed as cells undergo differentiation (Rajapakse, 
Perlman et al. 2009). In the future, combining computational enhancer predictions, experimental 
tests of distant CRMs, and global measurements of chromosome conformation (Lieberman-
Aiden, van Berkum et al. 2009) will help to further elucidate the mechanisms of gene regulation 
during this differentiation process. 
 
 
 	 ﾠ 168 
MATERIALS AND METHODS 
 
Proliferation and differentiation of human myoblasts in cell culture 
 
Adult primary human skeletal myoblasts (Lonza) were grown in SkGM-2 medium 
(Lonza). Myogenic differentiation was stimulated by switching the culture medium to DMEM-
F12 with 2% horse serum (Sigma) when the cells reached about 70% confluence. All time points 
referred to in this study are with respect to the time of switching to differentiation medium. The 
majority of the results presented here were obtained using adult male skeletal myoblasts; female 
skeletal myoblasts were used in one 3C experiment to confirm the reproducibility, and lack of 
gender-specificity, of the differentiation-specific physical interaction of the PDLIM3/SORBS2 
CRM. 
 
Chromosome Conformation Capture (3C) 
 
3C experiments were performed following previously described protocols (Dostie, 
Richmond et al. 2006). Briefly, approximately 5×107 human muscle cells were crosslinked in a 
final concentration of 1% formaldehyde and harvested at each of two timepoints: 48 h before and 
48 h after differentiation by serum deprivation. Chromatin extracted from these cells was 
digested with either an AflII or BglII restriction enzyme (New England Biolabs) and then 
incubated with T4 DNA ligase (New England Biolabs), such that regions of chromosome contact 
were ligated together. After reversing the formaldehyde crosslinks, physical interactions between 
genomic regions were detected with PCR primers specific for each ligated interaction product. 	 ﾠ 169 
Primer pairs with melting temperatures of 56–60 °C, within 2 °C of each other, and of 35–50% 
GC content, were designed to uniquely amplify an approximately 100–300 bp region straddling 
the location of potential ligation between two restriction fragments. PCR-amplified products 
were detected by quantitative real-time PCR (qPCR) on an iCycler (BioRad) with SybrGreen 
Supermix for iQ (BioRad) and standard protocols. The quantification by qPCR was validated by 
visualization on an agarose gel and quantification using QuantityOne gel image quantification 
software (BioRad). The qPCR quantification results were utilized for the final analysis. 
To control for differences in primer efficiency, DNA fragments generated from bacterial 
artificial chromosomes (BACs) spanning the genomic regions of interest were digested and 
randomly ligated (ACTA1: RP11-1111E20, PDLIM3/SORBS2: CTD-2559A19, CTD-2194A4, 
and RP11-78H20). Quantified PCR products from each 3C reaction were then normalized by the 
quantified results from the same PCR amplifications performed on this BAC control library. For 
those regions for which an ANOVA test of interaction frequencies within a given genomic 
region (excluding fragments within 15 kb of the fixed primer, which are likely to show high 
levels of interactions from random collisions (Dekker 2006)) indicated the presence of a 
significant peak (p<0.05) within the data, we tested the observed peaks for statistically 
significant differences in interaction level between timepoints using a Student's t-test. 
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